Staff Profile

CURRENTLY:

Emeritus Professor of Old Age Psychiatry, Newcastle University, UK

PREVIOUSLY:

Director, UK National Institute of Health Research, Dementias and Neurodegenerative Diseases Research Network (DeNDRoN) (2004 - 2015)

Clinical Director, Institute for Ageing and Health, Newcastle University (2007 – 2010)

DLB International Consortium Lead Theme Lead

Hon. Consultant in Old Age Psychiatry, Newcastle North Tyneside and Northumberland Mental Health NHS Trust

I have 777 articles listed on Google Scholar with 76,338 citations and H-Index 133 (August 2024).

http://scholar.google.co.uk/citations?user=g89IITsAAAAJ&hl=en

ESTEEM INDICATORS:

European Grand Prix for Alzheimer's Research 2018

Bengt Winblad Lifetime Achievement Award 2015 US Alzheimer's Association

Fellow of the Royal Society of Biology (FRSB) 2012

Lifetime Achievement Award 2008 UK Royal College of Psychiatrists

NIHR Inaugural Senior Investigator 2008

Fellow of the Academy of Medical Sciences (F Med Sci) 2004

Research Interests

My main research strategies centre upon longitudinal clinical assessment of patients with neurodegenerative disorders with follow up to death and request for brain autopsy.  Studies focussed upon Lewy body disease have contributed to the development of globally used Consensus criteria for the clinical and pathological diagnosis and management of dementia with Lewy bodies (DLB) and related disorders. I am a longstanding member of UK MRC CFAS www.cfas.ac.uk/ and have led several international multicentre trials of diagnostic and treatment agents.

• Articles

  • Babiloni C, Noce G, Tucci F, Jakhar D, Ferri R, Panerai S, Catania V, Soricelli A, Salvatore M, Nobili F, Arnaldi D, Fama F, Buttinelli C, Giubilei F, Onofrj M, Stocchi F, Vacca L, Radicati F, Fuhr P, Gschwandtner U, Ransmayr G, Parnetti L, Marizzoni M, D'Antonio F, Bruno G, De Lena C, Guntekin B, Yildirim E, Hanoglu L, Yener G, Hunerli D, Taylor J-P, Schumacher J, McKeith I, Frisoni GB, Antonini A, Ferreri F, Bonanni L, De Pandis MF, Del Percio C. Poor reactivity of posterior electroencephalographic alpha rhythms during the eyes open condition in patients with dementia due to Parkinson's disease. Neurobiology of Aging 2024, 135, 1-14.
  • Agarwal K, Backler W, Bayram E, Bloom L, Boeve BF, Cha J-H, Denslow M, Ferman TJ, Galasko D, Galvin JE, Gomperts SN, Irizarry MC, Kantarci K, Kaushik H, Kietlinski M, Koenig A, Leverenz JB, McKeith I, McLean PJ, Montine TJ, Moose SO, O'Brien JT, Panier V, Ramanathan S, Ringel MS, Scholz SW, Small J, Sperling RA, Taylor A, Taylor J-P, Ward RA, Witten L, Hyman BT. Lewy body dementia: Overcoming barriers and identifying solutions. Alzheimer's and Dementia 2024, epub ahead of print.
  • Wu LY, Real R, Martinez-Carrasco A, Chia R, Lawton MA, Shoai M, Bresner C, Blauwendraat C, Singleton AB, Ryten M, Scholz SW, Traynor BJ, Williams NM, Hu MTM, Ben-Shlomo Y, Grosset DG, Hardy J, Morris HR, Abramzon Y, Ahmed S, Alba C, Albert MS, Bacikova D, Barrett MJ, Beach TG, Bennett DA, Besser LM, Bigio EH, Boeve BF, Bohannan RC, Caraway CA, Palma J-A, Dalgard CL, Dickson D, Ding J, Faber K, Ferman T, Ferrucci L, Flanagan ME, Foroud TM, Ghetti B, Gibbs JR, Goate A, Goldstein D, Graff-Radford NR, Hu H-C, Hupalo D, Kaiser SM, Kaufmann H, Kim RC, Klein G, Kukull W, Kuzma A, Leverenz J, Lopez G, Mao Q, Martinez-McGrath E, Masliah E, Monuki E, Newell KL, Norcliffe-Kaufmann L, Perkins M, Pletnikova O, Renton AE, Resnick SM, Ross OA, Sabir MS, Scherzer CR, Serrano G, Shakkotai V, Sidransky E, Tanaka T, Tayebi N, Troncoso JC, Viollet C, Walton RL, Woltjer R, Wszolek ZK, Black SE, Gan-Or Z, Keith J, Masellis M, Rogaeva E, Aarsland D, Al-Sarraj S, Attems J, Ferrari R, Gentleman S, Hardy JA, Hodges AK, Love S, McKeith I, Morris CM, Palmer L, Pickering-Brown S, Reynolds RH, Thomas AJ, Tilley BS, Troakes C, Brett F, Brice A, Duyckaerts C, Lesage S, Brunetti M, Calvo A, Canosa A, Chio A, Floris G, Logroscino G, Zecca C, Clarimon J, Diez-Fairen M, Fortea J, Gonzalez-Aramburu I, Infante J, Lage C, Lleo A, Pastor P, Porcel-Molina L, Rodriguez-Rodriguez E, Sanchez-Juan P, Kruger R, May P, Xiromerisiou G. Investigation of the genetic aetiology of Lewy body diseases with and without dementia. Brain Communications 2024, 6(4).
  • Fernando R, Thomas A, Hamilton C, Durcan R, Barker S, Ciafone J, Barnett N, Olsen K, Firbank M, Roberts G, Lloyd J, Petrides G, Colloby S, Allan L, McKeith I, O'Brien J, Taylor JP, Donaghy PC. Identifying parkinsonism in mild cognitive impairment. Journal of the Neurological Sciences 2024, 458, 122941.
  • Babiloni C, Lopez S, Noce G, Ferri R, Panerai S, Catania V, Soricelli A, Salvatore M, Nobili F, Arnaldi D, Fama F, Massa F, Buttinelli C, Giubilei F, Stocchi F, Vacca L, Marizzoni M, D'Antonio F, Bruno G, De Lena C, Guntekin B, Yildirim E, Hanoglu L, Yener G, Yerlikaya D, Paul Taylor J, Schumacher J, McKeith I, Bonanni L, Pantano P, Piervincenzi C, Petsas N, Frisoni GB, Del Percio C, Carducci F. Relationship between default mode network and resting-state electroencephalographic alpha rhythms in cognitively unimpaired seniors and patients with dementia due to alzheimer’s disease. Cerebral Cortex 2023, 33(20), 10514-10527.
  • Donaghy PC, Hamilton C, Durcan R, Lawley S, Barker S, Ciafone J, Barnett N, Olsen K, Firbank M, Roberts G, Lloyd J, Allan LM, Saha R, McKeith IG, O'Brien JT, Taylor J-P, Thomas AJ. Clinical symptoms in mild cognitive impairment with Lewy bodies: Frequency, time of onset, and discriminant ability. European Journal of Neurology 2023, 30(6), 1585-1593.
  • Ghanem SS, Majbour NK, Vaikath NN, Ardah MT, Erskine D, Jensen NM, Fayyad M, Sudhakaran IP, Vasili E, Melachroinou K, Abdi IY, Poggiolini I, Santos P, Dorn A, Carloni P, Vekrellis K, Attems J, McKeith I, Outeiro TF, JEnsen PH, El-Agnaf OMA. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proceedings of the National Academy of Sciences 2022, 119(15), e2109617119.
  • Babiloni C, Lorenzo I, Lizio R, Lopez S, Tucci F, Ferri R, Soricelli A, Nobili F, Arnaldi D, Fama F, Buttinelli C, Giubilei F, Cipollini V, Onofrj M, Stocchi F, Vacca L, Fuhr P, Gschwandtner U, Ransmayr G, Aarsland D, Parnetti L, Marizzoni M, D'Antonio F, De Lena C, Guntekin B, Yildirim E, Hanoglu L, Yener G, Gunduz DH, Taylor JP, Schumacher J, McKeith I, Frisoni GB, De Pandis MF, Bonanni L, Percio CD, Noce G. Reactivity of posterior cortical electroencephalographic alpha rhythms during eyes opening in cognitively intact older adults and patients with dementia due to Alzheimer's and Lewy body diseases. Neurobiology of Aging 2022, 115, 88-108.
  • Hamilton CA, Matthews FE, Donaghy PC, Taylor JP, O'Brien JT, Barnett NA, Olsen K, Durcan R, Roberts G, Ciafone J, Barker S, Firbank MJ, McKeith IG, Thomas AJ. Progression to dementia in mild cognitive impairment with Lewy bodies or Alzheimer’s disease. Neurology 2021, 96(22), e2685-e2693.
  • Matar E, White SR, Taylor J-P, Thomas A, McKeith IG, Kane JPM, Surendranathan A, Halliday GM, Lewis SJG, O'Brien JT. Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months. Neurology 2021, 97(10), e1031-e1040.
  • Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G, Hortobagyi T, Jellinger K, Kovacs GG, Lee EB, Love S, McAleese KE, Nelson PT, Neumann M, Parkkinen L, Polvikoski T, Sikorska B, Smith C, Grinberg LT, Thal DR, Trojanowski JQ, McKeith IG. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathologica 2021, 141(2), 159-172.
  • Surendranathan A, Kane J, Bentley A, Barker S, McNally R, Bamford C, Taylor J-P, Thomas A, McKeith I, Burn D, O'Brien JT. Introduction of an assessment toolkit associated with increased rate of DLB diagnosis. Alzheimer's Research & Therapy 2021, 13, 50.
  • O'Brien JT, McKeith IG, Thomas AJ, Bamford C, Vale L, Hill S, Allan L, Finch T, McNally R, Hayes L, Surendranathan A, Kane JPM, Dunn S, Bentley A, Barker S, Mason J, Burn D, Taylor J-P. Introduction of a management toolkit for Lewy body dementia: A pilot cluster randomised trial. Movement Disorders 2021, 36(1), 143-151.
  • O'Brien JT, Taylor JP, Thomas A, Bamford C, Vale L, Hill S, Allan L, Finch T, McNally R, Hayes L, Surendranathan A, Kane J, Chrysos AE, Bentley A, Barker S, Mason J, Burn D, McKeith I. DTC-RP-PG-0311-12001: Improving the Diagnosis and Management of Neurodegenerative Dementia of Lewy Body Type in the NHS (DIAMOND-Lewy Programme). NIHR Journals Library 2021, 9(7).
  • Hamilton CA, Matthews FE, Donaghy PC, Taylor JP, O'Brien JT, Barnett N, Olsen K, Lloyd J, Petrides G, McKeith IG, Thomas AJ. Cognitive decline in mild cognitive impairment with Lewy bodies or Alzheimer’s disease: a prospective cohort study. American Journal of Geriatric Psychiatry 2021, 29(3), 272-284.
  • San-Martin R, Fraga FJ, Del Percio C, Lizio R, Noce G, Nobili F, Arnaldi D, D'Antonio F, De Lena C, Guntekin B, Hanoglu L, Taylor JP, McKeith I, Stocchi F, Ferri R, Onofrj M, Lopez S, Bonanni L, Babiloni C. Classification of Patients with Alzheimer's Disease and Dementia with Lewy Bodies using Resting EEG Selected Features at Sensor and Source Levels: A Proof-of-Concept Study. Current Alzheimer Research 2021, 18(12), 956-969.
  • Kurzawa-Akanbi M, Tammireddy S, Fabrik I, Gliaudelyte L, Doherty MK, Heap R, Matecko-Burmann I, Burmann BM, Trost M, Lucocq JM, Gherman AV, Fairfoul G, Singh P, Burte F, Green A, McKeith IG, Härtlova A, Whitfield PD, Morris CM. Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders. Acta Neuropathologica 2021, 142, 961-984.
  • McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, Galvin JE, Galasko D, Goldman JG, Gomperts SN, Honig LS, Ikeda M, Leverenz J, Lewis SJG, Marder KS, Masellis M, Salmon DP, Taylor JP, Tsuang DW, Walker Z, Tiraboschi P. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 2020, 94(17), 743-755.
  • Hamilton CA, Matthews FE, Donaghy PC, Taylor JP, O'Brien JT, Barnett N, Olsen K, McKeith IG, Thomas AJ. Prospective predictors of decline versus stability in mild cognitive impairment with Lewy bodies or Alzheimer’s disease. Psychological Medicine 2020, 51(15), 2590-2598.
  • Durcan R, Donaghy PC, Barnett NA, Olsen K, Yarnall AJ, Taylor J-P, McKeith I, O'Brien JT, Thomas AJ. Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodies. International Journal of Geriatric Psychiatry 2020, 34(7), 990-998.
  • Surendranathan A, Kane JPM, Bentley A, Barker SAH, Taylor J-P, Thomas AJ, Allan LM, McNally RJQ, James PW, McKeith IG, Burn DJ, O'Brien JT. Clinical diagnosis of Lewy body dementia. BJ Psych Open 2020, 6(4), e61.
  • Pascarelli MT, Del Percio C, De Pandis MF, Ferri R, Lizio R, Noce G, Lopez S, Rizzo M, Soricelli A, Nobili F, Arnaldi D, Fama F, Orzi F, Buttinelli C, Giubilei F, Salvetti M, Cipollini V, Franciotti R, Onofri M, Fuhr P, Gschwandtner U, Ransmayr G, Aarsland D, Parnetti L, Farotti L, Marizzoni M, D'Antonio F, De Lena C, Guntekin B, Hanoglu L, Yener G, Emek-Savas DD, Triggiani AI, Taylor JP, McKeith I, Stocchi F, Vacca L, Hampel H, Frisoni GB, Bonanni L, Babiloni C. Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms. Clinical Neurophysiology 2020, 131(11), 2716-2731.
  • Babiloni C, Pascarelli MT, Lizio R, Noce G, Lopez S, Rizzo M, Ferri R, Soricelli A, Nobili F, Arnaldi D, Fama F, Orzi F, Buttinelli C, Giubilei F, Salvetti M, Cipollini V, Bonanni L, Franciotti R, Onofrj M, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Aarsland D, Parnetti L, Farotti L, Marizzoni M, D'Antonio F, De Lena C, Guntekin B, Hanoglu L, Yener G, Emek-Savas DD, Triggiani AI, Taylor JP, McKeith I, Sticchi F, Vacca L, Hampel H, Frisoni GB, De Pandis MF, Del Percio C. Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study. Neurobiology of Aging 2020, 91, 88-111.
  • Erskine D, Taylor JP, Thomas A, Collerton D, McKeith I, Khundakar A, Attems J, Morris C. Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies. Neuroscience Bulletin 2019, 35, 295-300.
  • Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, Domoto-Reilly K, Duda J, Gomperts S, Graff-Radford N, Holden S, Honig L, Huddleston D, Lippa C, Litvan I, Manning C, Marder K, Moussa C, Onyike C, Pagan F, Pantelyat A, Pelak V, Poston K, Quinn J, Richard I, Rosenthal LS, Sabbagh M, Scharre D, Sha S, Shill H, Torres-Yaghi Y, Christie T, Graham T, Richards I, Koehler M, Boeve B. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimer's Research and Therapy 2019, 11(1), 23.
  • Babiloni C, Del Percio C, Lizio R, Noce G, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Catania V, Nobili F, Arnaldi D, Fama F, Orzi F, Buttinelli C, Giubilei F, Bonanni L, Franciotti R, Onofrj M, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Fraioli L, Parnetti L, Farotti L, Pievani M, D'Antonio F, De Lena C, Guntekin B, Hanoglu L, Yener G, Emek-Savas DD, Triggiani AI, Taylor JP, McKeith I, Stocchi F, Vacca L, Frisoni GB, De Pandis MF. Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms. Neurobiology of Aging 2019, 73, 9-20.
  • Swarup V, Hinz FI, Rexach JE, Noguchi K, Toyoshiba H, Oda A, Hirai K, Sarkar A, Seyfried NT, Cheng C, Haggarty SJ, International Frontotemporal Dementia Genetics Consortium, (Includes, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Jaros E), Grossman M, Van Deerlin VM, Trojanowski JQ, Lah JJ, Levey AI, Kondou S, Geschwind DH. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. Nature Medicine 2019, 25, 152-164.
  • Bonham LW, Steele NZR, Karch CM, Broce I, Geier EG, Wen NL, Momeni P, Hardy J, Miller ZA, Gorno-Tempini ML, Hess CP, Lewis P, Miller BL, Seeley WW, Manzoni C, Desikan RS, Baranzini SE, Ferrari R, Yokoyama JS, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JBJ, Dobson-Stone C, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernandez I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Albani D, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimon J, Lleo A, Blesa R, Landqvist Waldo M, Nilsson K, Nilsson C, Mackenzie IRA, Hsiung G-YR, Mann DMA, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JCM, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Cruts M, VanBroeckhoven C, Cappa SF, Leber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Karydas AM, Rosen H, van Swieten JC, Dopper EGP, Seelaar H, Pijnenburg YAL, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang H-H, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebouvier T, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia. Scientific Reports 2019, 9, 10854.
  • McAleese KE, Graham S, Dey M, Walker L, Erskine D, Johnson M, Johnston E, Thomas AJ, McKeith IG, DeCarli C, Attems J. Extravascular fibrinogen in the white matter of Alzheimer’s disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer’s disease. Brain Pathology 2019, 29(3), 414-424.
  • Thomas A, Donaghy P, Roberts G, Colloby SJ, Barnett NA, Petrides G, Lloyd J, Olsen K, Taylor J-P, McKeith I, O'Brien JT. Diagnostic Accuracy of Dopaminergic Imaging in Prodromal Dementia with Lewy Bodies. Psychological Medicine 2019, 49(3), 396-402.
  • Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn DJ, Donaghy P, Morris CM, Taylor JP, Thomas AJ, Attems J, McKeith IG. Dementia with Lewy bodies: an update and outlook. Molecular Neurodegeneration 2019, 14, 5.
  • Elder GJ, Colloby SJ, Firbank MJ, McKeith IG, Taylor J-P. Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial. Alzheimer's Research and Therapy 2019, 11(1), 9.
  • Babiloni C, Del Percio C, Pascarelli MT, Lizio R, Noce G, Lopez S, Rizzo M, Ferri R, Soricelli A, Nobili F, Arnaldi D, Fama F, Orzi F, Buttinelli C, Giubilei F, Salvetti M, Cipollini V, Franciotti R, Onofrj M, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Aarsland D, Parnetti L, Farotti L, Marizzoni M, D'Antonio F, De Lena C, Guntekin B, Hanoglu L, Yener G, Emek-Savas DD, Triggiani AI, Taylor JP, McKeith I, Stocchi F, Vacca L, Hampel H, Frisoni GB, De Pandis MF, Bonanni L. Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases. Neurobiology of Aging 2019, 77, 112-127.
  • Petyuk VA, Chang R, Ramirez-Restrepo M, Beckmann ND, Henrion MYR, Piehowski PD, Zhu K, Wang S, Clarke J, Huentelman MJ, Xie F, Andreev V, Engel A, Guettoche T, Navarro L, De Jager P, Schneider JA, Morris CM, McKeith IG, Perry RH, Lovestone S, Woltjer RL, Beach TG, Sue LI, Serrano GE, Lieberman AP, Albin RL, Ferrer I, Mash DC, Hulette CM, Ervin JF, Reiman EM, Hardy JA, Bennett DA, Schadt E, Smith RD, Myers AJ. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 2018, 141(9), 2721-2739.
  • Thomas AJ, Taylor JP, McKeith I, Bamford C, Burn D, Allan L, O'Brien J. Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study. International Journal of Geriatric Psychiatry 2018, 33(10), 1293-1304.
  • Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J, Morris CM. Regional levels of physiological α-synuclein are directly associated with Lewy body pathology. Acta Neuropathologica 2018, 135(1), 153-154.
  • Connors MH, Quinto L, McKeith I, Brodaty H, Allan L, Bamford C, Thomas A, Taylor J-P, O'Brien JT. Non-pharmacological interventions for Lewy body dementia: a systematic review. Psychological Medicine 2018, 48(11), 1749-1758.
  • Donaghy PC, Taylor JP, O'Brien JT, Barnett N, Olsen K, Colloby SJ, Lloyd J, Petrides G, McKeith IG, Thomas AJ. Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies. Psychological Medicine 2018, 48(14), 2384-2390.
  • Erskine D, Ding J, Thomas AJ, Kaganovich A, Khundakar AA, Hanson PS, Taylor JP, McKeith IG, Attems J, Cookson MR, Morris CM. Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies. Movement Disorders 2018, 33(6), 982-991.
  • Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor J-P. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment. Movement Disorders 2018, 33(4), 503-510.
  • Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor J-P, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, Burn DJ, O'Brien JT. Clinical prevalence of Lewy body dementia. Alzheimer's Research & Therapy 2018, 10, 19.
  • Elder GJ, Ashcroft J, da Silva Morgan K, Kulsum MU, Banerjee R, Chatterjee P, Firbank MJ, McKeith IG, Kumar H, Taylor JP. Transcranial direct current stimulation in Parkinson's disease dementia: A randomised double-blind crossover trial. Brain Stimulation 2017, 10(6), 1150-1151.
  • Mcaleese KE, Walker L, Erskine D, Thomas AJ, Mckeith IG, Attems J. TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing. Brain Pathology 2017, 27(4), 472-479.
  • Donaghy PC, Barnett N, Olsen K, Taylor J-P, McKeith IG, O'Brien JT, Thomas AJ. Symptoms associated with Lewy body disease in mild cognitive impairment. International Journal of Geriatric Psychiatry 2017, 32(11), 1163-1171.
  • Erskine D, Thomas AJ, Attems J, Taylor JP, McKeith IG, Morris CM, Khundakar AA. Specific patterns of neuronal loss in the pulvinar nucleus in dementia with Lewy bodies. Movement Disorders 2017, 32(3), 414-422.
  • Walker L, McAleese KE, Johnson M, Khundakar AA, Erskine D, Thomas AJ, McKeith IG, Attems J. Quantitative neuropathology: an update on automated methodologies and implicationsfor large scale cohorts. Journal of Neural Transmission 2017, 124(6), 671-683.
  • McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor J-P, Thomas AJ, McKeith IG, De Carli C, Attems J. Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathologica 2017, 134(3), 459-473.
  • Erskine D, Thomas AJ, Taylor JP, Savage MA, Attems J, McKeith IG, Morris CM, Khundakar AA. Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies. The American Journal of Geriatric Psychiatry 2017, 25(6), 595-604.
  • Cummings J, Scheltens P, McKeith I, Blesa R, Harrison JE, Bertolucci PHF, Rockwood K, Wilkinson D, Wijker W, Bennett DA, Shah RC. Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease. Journal of Alzheimer's Disease 2017, 55(3), 1131-1139.
  • Thomas AJ, Taylor JP, Mckeith I, Bamford C, Burn D, Allan L, O'Brien J. Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: Feasibility study within the DIAMOND Lewy study. International Journal of Geriatric Psychiatry 2017, 32(12), 1280-1304.
  • Knapp M, King D, Romeo R, Adams J, Baldwin A, Ballard C, Banerjee S, Barber R, Bentham P, Brown RG, Burns A, Dening T, Findlay D, Holmes C, Johnson T, Jones R, Katona C, Lindesay J, Macharouthu A, McKeith I, McShane R, O'Brien JT, Phillips PPJ, Sheehan B, Howard R. Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial). International Journal of Geriatric Psychiatry 2017, 32(12), 1205-1216.
  • Thomas AJ, Attems J, Colloby SJ, O'Brien JT, Mckeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Autopsy validation of ¹²³ I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 2017, 88(3), 276-283.
  • Urwyler P, Nef T, Müri R, Archibald N, Makin SM, Collerton D, Taylor JP, Burn D, McKeith I, Mosimann UP. Visual Hallucinations in Eye Disease and Lewy Body Disease. American Journal of Geriatric Psychiatry 2016, 24(5), 350-358.
  • Killen A, Flynn D, De Brún A, O'Brien N, O'Brien J, Thomas AJ, McKeith I, Taylor JP. Support and information needs following a diagnosis of dementia with Lewy bodies. International Psychogeriatrics 2016, 28(3), 495-501.
  • McKeith I, Taylor JP, Thomas A, Donaghy P, Kane J. Revisiting DLB Diagnosis: A Consideration of Prodromal DLB and of the Diagnostic Overlap With Alzheimer Disease. Journal of Geriatric Psychiatry and Neurology 2016, 29(5), 249-253.
  • Keogh MJ, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers KL, Hussein RI, Hudson G, Pyle A, Cordell HJ, Attems J, McKeith IG, O'Brien JT, Burn DJ, Morris CM, Thomas AJ, Chinnery PF. Exome sequencing in dementia with Lewy bodies. Translational Psychiatry 2016, 6, e728.
  • Elder GJ, Colloby SJ, Lett DJ, O'Brien JT, Anderson KN, Burn DJ, McKeith IG, Taylor JP. Depressive symptoms are associated with daytime sleepiness and subjective sleep quality in dementia with Lewy bodies. International Journal of Geriatric Psychiatry 2016, 31(7), 765-770.
  • Colloby SJ, McKeith IG, Burn DJ, Wyper DJ, O'Brien JT, Taylor JP. Cholinergic and perfusion brain networks in Parkinson disease dementia. Neurology 2016, 87(2), 178-185.
  • Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP. Arguing against the proposed definition changes of PD. Movement Disorders 2016, 31(11), 1619-1622.
  • Khundakar AA, Hanson PS, Erskine D, Lax NZ, Roscamp J, Karyka E, Tsefou E, Singh P, Cockell SJ, Gribben A, Ramsay L, Blain PJ, Mosimann UP, Lett DJ, Elstner M, Turnbull DM, Xiang CC, Brownstein MJ, O'Brien JT, Taylor JP, Attems J, Thomas AJ, McKeith IG, Morris CM. Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations. Acta Neuropathologica Communications 2016, 4, 66.
  • Peraza LR, Colloby SJ, Firbank MJ, Greasy SG, McKeith IG, Kaiser M, O'Brien J, Taylor JP. Resting state in Parkinson’s disease dementia and dementia with Lewy bodies: Commonalities and differences. International Journal of Geriatric Psychiatry 2015, 30(11), 1135-1146.
  • Colloby SJ, McKeith IG, Wyper DJ, O'Brien JT, Taylor JP. Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [¹²³I]-QNB SPECT. Journal of Neurology 2015, 262(9), 2144-2153.
  • Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, Mak E, Cambridge V, Mason J, Thomas A, O'Brien JT. Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. American Journal of Psychiatry 2015, 172(8), 731-742.
  • Urwyler P, Nef T, Muri RM, Killen A, Collerton D, Burn D, McKeith I, Mosimann UP. Patient and Informant Views on Visual Hallucinations in Parkinson Disease. American Journal of Geriatric Psychiatry 2015, 23(9), 970-976.
  • Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown RG, Banerjee S, Adams J, Johnson T, Bentham P, Phillips PPJ. Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses. Lancet Neurology 2015, 14(12), 1171-1181.
  • Blanc F, Colloby SJ, Philippi N, de Petigny X, Jung B, Demuynck C, Phillipps C, Anthony P, Thomas A, Bing F, Lamy J, Martin-Hunyadi C, O'Brien JT, Cretin B, McKeith I, Armspach JP, Taylor JP. Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages. PLoS ONE 2015, 10(6), e0127396.
  • Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG. Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β Normal 0 false false false EN-GB X-NONE X-NONE -amyloid load. Neurology 2015, 84(5), 496-499.
  • Erskine D, Taylor JP, Firbank MJ, Patterson L, Onofrj M, O'Brien JT, McKeith IG, Attems J, Thomas AJ, Morris CM, Khundakar AA. Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies. Neuropathology and Applied Neurobiology 2015, 42(4), 366–376.
  • Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ, Masuda-Suzukake M, Hasegawa M, Rollinson S, Pickering-Brown S, Robinson AC, Davidson YS, Mann DMA. Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene. Neuropathology and Applied Neurobiology 2015, 41(5), 601-612.
  • Urwyler P, Nef T, Killen A, Collerton D, Thomas A, Burn D, McKeith I, Mosimann UP. Visual complaints and visual hallucinations in Parkinson's disease. Parkinsonism & Related Disorders 2014, 20(3), 318-322.
  • Lee DR, McKeith I, Mosimann U, Ghosh-Nodial A, Grayson L, Wilson B, Thomas AJ. The Dementia Cognitive Fluctuation Scale, a New Psychometric Test for Clinicians to Identify Cognitive Fluctuations in People with Dementia. American Journal of Geriatric Psychiatry 2014, 22(9), 926-935.
  • O'Brien JT, Oertel WH, McKeith IG, Grosset DG, Walker Z, Tatsch K, Tolosa E, Sherwin PF, Grachev ID. Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials. BMJ Open 2014, 4(7), e005122.
  • Seibyl JP, Kupsch A, Booij J, Grosset DG, Costa DC, Hauser RA, Darcourt J, Bajaj N, Walker Z, Marek K, McKeith I, O'Brien JT, Tatsch K, Tolosa E, Dierckx RA, Grachev ID. Individual-Reader Diagnostic Performance and Between-Reader Agreement in Assessment of Subjects with Parkinsonian Syndrome or Dementia Using ¹²³I-Ioflupane Injection (DaTscan) Imaging. Journal of Nuclear Medicine 2014, 55(8), 1288-1296.
  • Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JBJ, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernandez I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimon J, Lleo A, Blesa R, Waldo ML, Nilsson K, Nilsson C, Mackenzie IRA, Hsiung GYR, Mann DMA, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JCM, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EGP, Seelaar H, Al Pijnenburg Y, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurology 2014, 13(7), 686-699.
  • Mohamed NE, Howlett DR, Ma L, Francis PT, Aarsland D, Ballard CG, McKeith IG, Chen CP, Lai MKP. Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias. Journal of Neural Transmission 2014, 121(1), 71-78.
  • Killen AJ, Firbank MJ, Collerton D, Clarke MP, Jefferis J, Taylor J-P, McKeith IG, Mosimann U. The assessment of cognition in visually impaired older adults. Age and Ageing 2013, 42(1), 98-102.
  • Wood JS, Firbank MJ, Mosimann UP, Watson R, Barber R, Blamire AM, O'Brien JT. Testing Visual Perception in Dementia with Lewy Bodies and Alzheimer Disease. American Journal of Geriatric Psychiatry 2013, 21(6), 501-508.
  • Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Bohr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG. Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology 2013, 72(1), 53-60.
  • Colloby SJ, Taylor J-P, Davison CM, Lloyd JJ, Firbank MJ, McKeith IG, O'Brien JT. Multivariate spatial covariance analysis of ^99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer’s disease: utility in differential diagnosis. Journal of Cerebral Blood Flow & Metabolism 2013, 33(4), 612-618.
  • Wood JS, Watson R, Firbank MJ, Mosimann UP, Barber R, Blamire AM, O'Brien JT. Longitudinal testing of visual perception in dementia with Lewy bodies and Alzheimer’s disease. International Journal of Geriatric Psychiatry 2013, 28(6), 567-572.
  • Lee DR, McKeith I, Mosimann U, Ghosh-Nodyal A, Thomas AJ. Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms. International Journal of Geriatric Psychiatry 2013, 28(2), 135-141.
  • Vardy ERLC, Ford AH, Gallagher P, Watson R, McKeith IG, Blamire A, O'Brien JT. Distinct cognitive phenotypes in Alzheimer's disease in older people. International Psychogeriatrics 2013, 25(10), 1659-1666.
  • Taylor JP, Colloby SJ, McKeith IG, O'Brien JT. Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in Dementia with Lewy bodies. International Psychogeriatrics 2013, 25(12), 1917-1928.
  • Kohler S, Allardyce J, Verhey FRJ, McKeith IG, Matthews F, Brayne C, Savva GM, Med Res Council Cognitive Function. Cognitive Decline and Dementia Risk in Older Adults With Psychotic Symptoms: A Prospective Cohort Study. American Journal of Geriatric Psychiatry 2013, 21(2), 119-128.
  • Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, Brayne C, on behalf of the Medical Research Council Cognitive Function and Ageing Collaboration. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 2013, 382(9902), 1405-1412.
  • Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, DeDeyn PP, Van Broeckhoven C, Mann DM, Snowden J, Pickering-Brown S, Halliwell N, Davidson Y, Gibbons L, Harris J, Sheerin UM, Bras J, Hardy J, Clark L, Marder K, Honig LS, Berg D, Maetzler W, Brockmann K, Gasser T, Novellino F, Quattrone A, Annesi G, De Marco EV, Rogaeva E, Masellis M, Black SE, Bilbao JM, Foroud T, Ghetti B, Nichols WC, Pankratz N, Halliday G, Lesage S, Klebe S, Durr A, Duyckaerts C, Brice A, Giasson BI, Trojanowski JQ, Hurtig HI, Tayebi N, Landazabal C, Knight MA, Keller M, Singleton AB, Wolfsberg TG, Sidransky E. A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies. JAMA Neurology 2013, 70(6), 727-735.
  • Taylor JP, Firbank MJ, He JB, Barnett N, Pearce S, Livingstone A, Vuong Q, McKeith IG, O'Brien JT. Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study. British Journal of Psychiatry 2012, 200(6), 491-498.
  • Reeve AK, Park TK, Jaros E, Campbell GR, Lax NZ, Hepplewhite PD, Krishnan KJ, Elson JL, Morris CM, McKeith IG, Turnbull DM. Relationship Between Mitochondria and α-Synuclein: A Study of Single Substantia Nigra Neurons. Archives of Neurology 2012, 69(3), 385-393.
  • Stephan BC, Matthews FE, Hunter S, Savva GM, Bond J, McKeith IG, Ince P, Brayne C, Medical Research Council Cognitive Function and Ageing Study. Neuropathological Profile of Mild Cognitive Impairment from a Population Perspective. Alzheimer Disease and Associated Disorders 2012, 26(3), 205-212.
  • Keage HAD, Ince PG, Matthews FE, Wharton SB, McKeith IG, Brayne C, MRC CFAS CC75C. Impact of Less Common and "Disregarded" Neurodegenerative Pathologies on Dementia Burden in a Population-Based Cohort. Journal of Alzheimer's Disease 2012, 28(2), 485-493.
  • Kurzawa-Akanbi M, Hanson PS, Blain PG, Lett DJ, McKeith IG, Chinnery PF, Morris CM. Glucocerebrosidase Mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease. Journal of Neurochemistry 2012, 123(2), 298-309.
  • Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R. Frontotemporal Dementia in Elderly Individuals. Archives of Neurology 2012, 69(8), 1052-1060.
  • Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P. Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease. New England Journal of Medicine 2012, 366(10), 893-903.
  • Walker Z, McKeith I, Rodda J, Qassem T, Tatsch K, Booij J, Darcourt J, O'Brien J. Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study. BMJ Open 2012, 2(1), e000380.
  • Stephan BC, Matthews FE, Ma B, Muniz G, Hunter S, Davis D, McKeith IG, Foster G, Ince PG, Brayne C. Alzheimer and Vascular Neuropathological Changes Associated with Different Cognitive States in a Non-Demented Sample. Journal of Alzheimer's Disease 2012, 29(2), 309-318.
  • Taylor JP, Firbank M, Barnett N, Pearce S, Livingstone A, Mosimann U, Eyre JA, McKeith IG, O'Brien JT. Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study. British Journal of Psychiatry 2011, 199(6), 492-500.
  • Narayan SK, Saxby BK, Firbank MJ, O'Brien JT, Harrington F, McKeith IG, Hansrani M, Stansby G, Ford GA. Plasma homocysteine and cognitive decline in older hypertensive subjects. International Psychogeriatrics 2011, 23(10), 1607-1615.
  • Baborie A, Griffiths TD, Jaros E, McKeith IG, Burn DJ, Richardson A, Ferrari R, Moreno J, Momeni P, Duplessis D, Pal P, Rollinson S, Pickering-Brown S, Thompson JC, Neary D, Snowden JS, Perry R, Mann DMA. Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathologica 2011, 121(3), 365-371.
  • Howard R, Phillips P, Johnson T, O'Brien J, Sheehan B, Lindesay J, Bentham P, Burns A, Ballard C, Holmes C, McKeith I, Barber R, Dening T, Ritchie C, Jones R, Baldwin A, Passmore P, Findlay D, Hughes A, Macharouthu A, Banerjee S, Jones R, Knapp M, Brown RG, Jacoby R, Adams J, Griffin M, Gray R. Determining the minimum clinically important differences for outcomes in the DOMINO trial. International Journal of Geriatric Psychiatry 2011, 26(8), 812-817.
  • O'Brien JT, Burns A, on behalf of the BAP Dementia Consensus Group. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. Journal of Psychopharmacology 2011, 25(8), 997-1019.
  • Kane JPM. Batman and Psychiatry - Psychiatry in the movies. British Journal of Psychiatry 2011, 199, 359-359.
  • Matthews F, Muniz-Terrera G, McKeith I, Brayne C. Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance. International Journal of Geriatric Psychiatry 2010, 25(7), 719-724.
  • Hutchings D, Vanoli A, McKeith I, Brotherton S, Mcnamee P, Bond J. Good days and bad days: The lived experience and perceived impact of treatment with cholinesterase inhibitors for Alzheimer's disease in the United Kingdom. Dementia 2010, 9(3), 409-425.
  • Hutchings D, Vanoli A, McKeith I, Brotherton S, Mcnamee P, Bond J. Cholinesterase inhibitors and alzheimer's disease: Patient, carer and professional factors influencing the use of drugs for Alzheimer's disease in the United Kingdom. Dementia 2010, 9(3), 427-443.
  • Savva GM, Zaccai J, Matthews FE, Davidson JE, McKeith I, Brayne C, Medical Research Council Cognitive Function and Ageing Study. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. British Journal of Psychiatry 2009, 194, 212-219.
  • Byford M, Brayne C, McKeith I, Chatfield M, Ince PG, Matthews FE, MRC CFAS Neuropathology Group. Lewy bodies and neuronal loss in subcortical areas and disability in non-demented older people: a population based neuropathological cohort study. BMC Geriatrics 2009, 9(22), 9.
  • Molloy S, Minett T, O'Brien JT, McKeith IG, Burn DJ. Levodopa Use and Sleep in Patients with Dementia with Lewy Bodies. Movement Disorders 2009, 24(4), 609-612.
  • O'Brien JT, McKeith IG, Walker Z, Tatsch K, Booij J, Darcourt J, Marquardt M, Reininger C, The DLB Study Group. Diagnostic accuracy of ¹²³I-FP-CIT SPECT in possible dementia with Lewy bodies. British Journal of Psychiatry 2009, 194(1), 34-39.
  • McKeith I. Commentary, DLB and PDD: the same or different? Is there a debate?. International Psychogeriatrics 2009, 21(2), 220-224.
  • Colloby SJ, Firbank MJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED, O'Brien JT. Alterations in nicotinic alpha4beta2 receptor binding in vascular dementia using 123I-5IA-85380 SPECT: Comparison with regional cerebral blood flow. Neurobiology of Aging 2009, 9.
  • Moreira T, Hughes JC, Kirkwood TBL, May CR, McKeith IG, Bond J. What explains variations in the clinical use of mild cognitive impairment (MCI) as a diagnostic category?. International Psychogeriatrics 2008, 20(4), 697-709.
  • Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C, Medical Research Council Cognitive Function and Ageing Study. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?. Journal of the American Geriatrics Society 2008, 56(8), 1424-1433.
  • Taylor J-P, Rowan EN, Lett DJ, O'Brien JT, McKeith IG, Burn DJ. Poor attentional function predicts cognitive decline in patients with non-demented Parkinson’s disease independent of motor phenotype. Journal of Neurology, Neurosurgery and Psychiatry 2008, 79(12), 1318-1323.
  • Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG. Patterns and stages of α-synucleinopathy: Relevance in a population-based cohort. Neurology 2008, 70(13), 1042-1048.
  • O'Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED. Nicotinic α4β2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations. NeuroImage 2008, 40(3), 1056-1063.
  • Stephan BC, Brayne C, McKeith IG, Bond J, Matthews FE, Medical Research Council Cognitive Function and Ageing Study. Mild cognitive impairment in the older population: Who is missed and does it matter?. International Journal of Geriatric Psychiatry 2008, 23(8), 863-871.
  • Wilcock GK, Black SE, Hendrix SB, Zavitz KH, Swaab EA, Laughlin MA, on behalf of the Tarenflurbil Phase II Study Investigators. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial. Lancet Neurology 2008, 7(6), 483-493.
  • Saxby BK, Harrington F, Wesnes K, McKeith IG, Ford GA. Candesartan and cognitive decline in older patients with hypertension: A substudy of the SCOPE trial. Neurology 2008, 70(19), 1858-1866.
  • Mukaetova-Ladinska EB, Milne J, Andras A, Abdel-All Z, Cerejeira J, Greally E, Robson J, Jaros E, Perry R, McKeith IG, Brayne C, Xuereb J, Cleghorn A, Doherty J, McIntosh G, Milton I. Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes. Dementia and Geriatric Cognitive Disorders 2008, 26(1), 32-42.
  • Mosimann UP, Collerton D, Dudley R, Meyer TD, Graham G, Dean JL, Bearn D, Killen A, Dickinson L, Clarke MP, McKeith IG. A semi-structured interview to assess visual hallucinations in older people. International Journal of Geriatric Psychiatry 2008, 23(7), 712-718.
  • Colloby SJ, Firbank MJ, Pakrasi SE, Lloyd JJ, Driver I, McKeith IG, Williams ED, O'Brien JT. A comparison of Tc-99m-exametazime and I-123-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. International Psychogeriatrics 2008, 20(6), 1124-1140.
  • O'Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED. α4β2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography. Journal of Neurology, Neurosurgery and Psychiatry 2007, 78(4), 356-361.
  • Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van Deerlin V, de Silva R, Hardy J. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiology of Disease 2007, 25(3), 561-570.
  • Piggott MA, Ballard CG, Dickinson HO, McKeith IG, Perry RH, Perry EK. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. International Journal of Neuropsychopharmacology 2007, 10(2), 231-244.
  • Boddy F, Rowan EN, Lett D, O'Brien JT, McKeith IG, Burn DJ. Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy Bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry 2007, 22(6), 529-535.
  • McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurology 2007, 6(4), 305-313.
  • Piggott MA, Ballard CG, Rowan E, Holmes C, McKeith IG, Jaros E, Perry RH, Perry EK. Selective loss of dopamine d2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Synapse 2007, 61(11), 903-911.
  • Matthews FE, McKeith I, Bond J, Brayne C. Reaching the population with dementia drugs: What are the challenges?. International Journal of Geriatric Psychiatry 2007, 22(7), 627-631.
  • Pakrasi S, Colloby SJ, Firbank MJ, Perry EK, Wyper DJ, Owens J, McKeith IG, Williams ED, O'Brien JT. Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT. Journal of Neurology 2007, 254(7), 907-913.
  • Ziabreva I, Ballard C, Johnson M, Larsen JP, McKeith I, Perry R, Aarsland D, Perry E. Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit. Neuropathology and Applied Neurobiology 2007, 33(5), 586-590.
  • Rowan E, McKeith IG, Saxby BK, O'Brien JT, Burn D, Mosimann U, Newby J, Daniel S, Sanders J, Wesnes K. Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders 2007, 23(3), 161-167.
  • Stephan BC, Matthews FE, McKeith IG, Bond J, Brayne C, Medical Research Council Cognitive Function and Aging Study. Early cognitive change in the general population: how do different definitions work?. Journal of the American Geriatrics Society 2007, 55(10), 1534-1540.
  • Ballard C, Ziabreva I, Perry R, Larsen JP, O'Brien J, McKeith I, Perry E, Aarsland D. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2007, 67(11), 1931-1934.
  • Walker Z, Jaros E, Walker RWH, Lee L, Costa DC, Livingston G, Ince PG, Perry R, McKeith I, Katona CLE. Dementia with Lewy bodies: A comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. Journal of Neurology, Neurosurgery and Psychiatry 2007, 78(11), 1176-1181.
  • McKeith I. Dementia with Lewy bodies. Psychiatry 2007, 7(1), 20-23.
  • Weisman D, McKeith I. Dementia with Lewy bodies. Seminars in Neurology 2007, 27(1), 42-47.
  • Ballard CG, Chalmers KA, Todd C, McKeith IG, O'Brien JT, Wilcock G, Love S, Perry EK. Cholinesterase inhibitors reduce cortical A beta in dementia with Lewy bodies. Neurology 2007, 68(20), 1726-1729.
  • Bhasin M, Rowan E, Edwards K, McKeith I. Cholinesterase inhibitors in dementia with Lewy bodies - A comparative analysis. International Journal of Geriatric Psychiatry 2007, 22(9), 890-895.
  • Taylor JP, Colloby SJ, McKeith IG, Burn DJ, Williams D, Patterson J, O'Brien JT. Cholinesterase inhibitor use does not significantly influence the ability of I-123-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry 2007, 78(10), 1069-1071.
  • Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, McKeith IG, Kenny RA. Autonomic dysfunction in dementia. Journal of Neurology, Neurosurgery and Psychiatry 2007, 78(7), 671-677.
  • Collerton J, Collerton D, Arai Y, Barrass K, Eccles M, Jagger C, McKeith I, Saxby BK, Kirkwood T, Bond J, James O, Robinson L, Von Zglinicki T. A comparison of computerized and pencil-and-paper tasks in assessing cognitive function in community-dwelling older people in the Newcastle 85+ pilot study. Journal of the American Geriatrics Society 2007, 55(10), 1630-1635.
  • Allan L, McKeith I, Ballard C, Kenny RA. The prevalence of autonomic symptoms in dementia and their association with physical activity, activities of daily living and quality of life. Dementia and Geriatric Cognitive Disorders 2006, 22(3), 230-237.
  • Pimlott SL, Piggott M, Ballard C, McKeith I, Perry R, Kometa S, Owens J, Wyper D, Perry E. Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiology of Disease 2006, 21(1), 50-56.
  • Gotti C, Moretti M, Bohr I, Ziabreva I, Vailati S, Longhi R, Riganti L, Gaimarri A, McKeith IG, Perry RH, Aarsland D, Larsen JP, Sher E, Beattie R, Clementi F, Court JA. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiology of Disease 2006, 23(2), 481-489.
  • Burton EJ, McKeith IG, Burn DJ, Firbank MJ, O'Brien JT. Progression of white matter hyperintensities in Alzheimer disease, dementia with Lewy bodies, and Parkinson disease dementia: a comparison with normal aging. American Journal of Geriatric Psychiatry 2006, 14(10), 842-849.
  • Mukaetova-Ladinska EB, McKeith IG. Pathophysiology of synuclein aggregation in Lewy body disease. Mechanisms of Ageing and Development 2006, 127(2), 188-202.
  • Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry 2006, 77(5), 585-589.
  • McKeith IG, Rowan E, Askew K, Naidu A, Allan L, Barnett N, Lett D, Mosimann UP, Burn D, O'Brien JT. More severe functional impairment in dementia with Lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. American Journal of Geriatric Psychiatry 2006, 14(7), 582-588.
  • Colloby SJ, Pakrasi S, Firbank MJ, Perry EK, Piggott MA, Owens J, Wyper DJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) ¹²³I-QNB in dementia with Lewy bodies and Parkinson's disease dementia. NeuroImage 2006, 33(2), 423-429.
  • Maurer K, McKeith I, Cummings J, Ames D, Burns A. Has the management of Alzheimer's disease changed over the past 100 years?. Lancet 2006, 368(9547), 1619-1621.
  • Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu CC, Lane R. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Movement Disorders 2006, 21(11), 1899-1907.
  • Molloy SA, Rowan EN, O'Brien JT, McKeith IG, Wesnes K, Burn DJ. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry 2006, 77(12), 1323-1328.
  • Ballard C, Ziabreva I, Perry R, Larsen JP, O'Brien J, McKeith I, Perry E, Aarsland D. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006, 67(11), 1931-1934.
  • McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop. Journal of Alzheimer's Disease 2006, 9(Suppl. 3), 417-423.
  • McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop. JOURNAL OF ALZHEIMERS DISEASE 2006, 9, 417-423.
  • Mosimann UP, Rowan EN, Partington CE, Collerton D, Littlewood E, O'Brien JT, Burn DJ, McKeith IG. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies. American Journal of Geriatric Psychiatry 2006, 14(2), 153-160.
  • Collerton D, Perry E, McKeith I. Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations. Behavioral and Brain Sciences 2005, 28(6), 737-757.
  • Molloy S, McKeith IG, O'Brien JT, Burn DJ. The role of levodopa in the management of dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry 2005, 76(9), 1200-1203.
  • Ballard C, Morris C, Kalaria R, McKeith I, Perry R, Perry E. The K variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients. Dementia and Geriatric Cognitive Disorders 2005, 19(5-6), 357-360.
  • Matthews F, Brayne C, Arie T, Bond J, Copeland J, Day N, Devakumar D, Dewey M, Fairbairn A, Grimley-Evans J, Huppert F, Kay D, McCracken C, McKeith I, Morgan K, Paykel G. The incidence of dementia in England and Wales: Findings from the five identical sites of the MRC CFA Study. PLoS Medicine 2005, 2(8), e193.
  • Tam CWC, Burton EJ, McKeith IG, Burn DJ, O'Brien JT. Temporal lobe atrophy on MRI in Parkinson disease with dementia: A comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 2005, 64(5), 861-865.
  • Mosimann UP, Muri RM, Burn DJ, Felblinger J, O'Brien JT, McKeith IG. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain 2005, 128(6), 1267-1276.
  • Colloby SJ, Williams ED, Burn DJ, Lloyd JJ, McKeith IG, O'Brien JT. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT. European Journal of Nuclear Medicine and Molecular Imaging 2005, 32(10), 1176-1185.
  • Ballard CG, Perry RH, McKeith IG, Perry EK. Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies. International Journal of Geriatric Psychiatry 2005, 20(9), 872-875.
  • Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. Journal of Clinical Psychiatry 2005, 66(5), 633-637.
  • Teaktong T, Piggott MA, Mckeith IG, Perry RH, Ballard CG, Perry EK. Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies. Behavioural Brain Research 2005, 161(2), 299-305.
  • Firbank MJ, Burn DJ, McKeith IG, O'Brien JT. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies. International Journal of Geriatric Psychiatry 2005, 20(8), 776-782.
  • Firbank MJ, Molloy S, McKeith IG, Burn DJ, O'Brien JT. Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson's disease over one year. Journal of Neurology, Neurosurgery and Psychiatry 2005, 76(10), 1448-1451.
  • Ames D, Ballard C, Cream J, Shah A, Suh GH, McKeith I. For Debate: Should novel antipsychotics ever be used to treat the behavioral and psychological symptoms of dementia (BPSD)?. International Psychogeriatrics 2005, 17(1), 3-29.
  • McKeith I. Dementia with Lewy bodies. Psychiatry 2005, 4(1), 52-55.
  • Bohr IJ, Ray MA, McIntosh JM, Chalon S, Guilloteau D, McKeith IG, Perry RH, Clementi F, Perry EK, Court JA, Piggott MA. Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [I-125]alpha-conotoxinMII in the striatum and thalamus. Experimental Neurology 2005, 191(2), 292-300.
  • O'Brien JT, Firbank MJ, Mosimann UP, Burn DJ, McKeith IG. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Research - Neuroimaging 2005, 139(2), 79-88.
  • Burton EJ, McKeith IG, Burn DJ, O'Brien JT. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Movement Disorders 2005, 20(12), 1571-1576.
  • Wesnes KA, McKeith I, Edgar C, Emre M, Lane R. Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology 2005, 65(10), 1654-1656.
  • Nowotny P, Hinrichs AL, Smemo S, Kauwe JSK, Maxwell T, Holmans P, Hamshere M, Turic D, Jehu L, Hollingworth P, Moore P, Bryden L, Myers A, Doil LM, Tacey KM, Gibson AM, McKeith IG, Perry RH, Morris CM, Thal L, Morris JC, O'Donovan MC, Lovestone S, Grupe A, Hardy J, Owen MJ, Williams J, Goate A. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 2005, 136(1), 62-68.
  • Vollbach H, Heun R, Morris CM, Edwardson JA, McKeith IG, Jessen F, Schulz A, Maier W, Kolsch H. APOA1 polymorphism influences risk for early-onset nonfamiliar AD. Annals of Neurology 2005, 58(3), 436-441.
  • Thomas AJ, Burn DJ, Rowan EN, Littlewood E, Newby J, Cousins D, Pakrasi S, Richardson J, Sanders J, McKeith IG. A comparison of the efficacy of donepezil in parkinson's disease with dementia and dementia with lewy bodies. International Journal of Geriatric Psychiatry 2005, 20(10), 938-944.
  • Mosimann UP, Mather G, Wesnes KA, O'Brien JT, Burn DJ, McKeith IG. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 2004, 63(11), 2091-2096.
  • Colloby SJ, O'Brien JT, Fenwick JD, Firbank MJ, Burn DJ, McKeith IG, Williams ED. The application of statistical parametric mapping to I-123-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. NeuroImage 2004, 23(3), 956-966.
  • Walker Z, Costa DC, Walker RWH, Lee L, Livingston G, Jaros E, Perry R, McKeith I, Katona CLE. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison. Neurology 2004, 62(9), 1568-1572.
  • Johnson J, Hague SM, Hanson M, Gibson A, Wilson KE, Evans EW, Singleton AA, McInerney-Leo A, Nussbaum RL, Hernandez DG, Gallardo M, McKeith IG, Burn DJ, Ryu M, Hellstrom O, Ravina B, Eerola J, Perry RH, Jaros E, Tienari P, Weiser R, Gwinn-Hardy K, Morris CM, Hardy J, Singleton AB. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 2004, 63(3), 554-556.
  • Aarsland D, Mosimann UP, McKeith IG. Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies. Journal of Geriatric Psychiatry and Neurology 2004, 17(3), 164-171.
  • Gibson AM, Edwardson JA, Turnbull DM, McKeith IG, Morris CM, Chinnery PF. No evidence of an association between the T16189C mtDNA variant and late onset dementia. Journal of Medical Genetics 2004, 41(1), e7.
  • Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, Nagy Z, Perry EK, Joachim C, Jaros E, O'Brien JT, Perry RH, McKeith IG. Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy- Confirmed Dementia With Lewy Bodies. American Journal of Psychiatry 2004, 161(5), 843-849.
  • Ray M, Bohr I, McIntosh JM, Ballard C, McKeith I, Chalon S, Guilloteau D, Perry R, Perry E, Court JA, Piggott M. Involvement of alpha 6/alpha 3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [I-125]-alpha-conotoxin MII binding in the thalamus and striatum. Neuroscience Letters 2004, 372(3), 220-225.
  • McKeith IG. Introduction - An update on the diagnosis and treatment of dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders 2004, 17(s1), 1-2.
  • McKeith IG, Wesnes KA, Perry E, Ferrara R. Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. Dementia and Geriatric Cognitive Disorders 2004, 18(1), 94-100.
  • O'Brien JT, Colloby S, Fenwick J, Williams ED, Firbank M, Burn D, Aarsland D, McKeith IG. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with lewy bodies. Archives of Neurology 2004, 61(6), 919-925.
  • Mukaetova-Ladinska EB, McKeith IG. Delirium and dementia. Medicine 2004, 32(8), 44-47.
  • Ballmaier M, O'Brien JT, Burton EJ, Thompson PM, Rex DE, Narr KL, McKeith IG, DeLuca H, Toga AW. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: Diagnosis and gender effects. NeuroImage 2004, 23(1), 325-335.
  • Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: A comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004, 127(4), 791-800.
  • O'Brien JT, Lloyd A, McKeith I, Gholkar A, Ferrier N. A Longitudinal Study of Hippocampal Volume, Cortisol Levels, and Cognition in Older Depressed Subjects. American Journal of Psychiatry 2004, 161(11), 2081-2090.
  • Minett TSC, Thomas A, Wilkinson LM, Daniel SL, Sanders J, Richardson J, Littlewood E, Myint P, Newby J, McKeith IG. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia. International Journal of Geriatric Psychiatry 2003, 18(11), 988-993.
  • Collerton D, Burn D, McKeith I, O'Brien J. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dementia and Geriatric Cognitive Disorders 2003, 16(4), 229-237.
  • Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith IG, Quinn NP, Sethi KD. SIC Task Force Appraisal of Clinical Diagnostic Criteria for Parkinsonian Disorders. Movement Disorders 2003, 18, 467-486.
  • O'Brien KK, Saxby BK, Ballard CG, Grace J, Harrington F, Ford GA, O'Brien JT, Swan AG, Fairbairn AF, Wesnes K, Del Ser T, Edwardson JA, Morris CM, McKeith IG. Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics 2003, 13(4), 231-239.
  • Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. NeuroImage 2003, 20(2), 1309-1319.
  • Williams JG, Huppert FA, Matthews FE, Nickson J, MRC Cognitive Function and Ageing Study (MRC CFAS). Performance and normative values of a concise neuropsychological test (CAMCOG) in an elderly population sample. International Journal of Geriatric Psychiatry 2003, 18(7), 631-644.
  • Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, Holton J, Rossor MN, Skullerud K, Duyckaerts C, Cruz-Sanchez FF, Lantos PL. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neuroscience Letters 2003, 341(3), 177-180.
  • Shaw FE, Bond J, Richardson DA, Dawson P, Steen IN, McKeith IG, Kenny RA. Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial. British Medical Journal 2003, 326(7380), 6.
  • Almeida OP, Burton EJ, McKeith I, Gholkar A, Burn D, O'Brien JT. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2003, 16(2), 57-63.
  • Burn DJ, Rowan EN, Minett T, Sanders J, Myint P, Richardson J, Thomas A, Newby J, Reid J, O'Brien JT, McKeith IG. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Movement Disorders 2003, 18(8), 884-889.
  • Saxby BK, Harrington F, McKeith IG, Wesnes K, Ford GA. Effects of hypertension on attention, memory, and executive function in older adults. Health Psychology 2003, 22(6), 587-591.
  • Almeida OP, Burton EJ, Ferrier N, McKeith IG, O'Brien JT. Depression with late onset is associated with right frontal lobe atrophy. Psychological Medicine 2003, 33(4), 675-681.
  • Lippa CF, McKeith I. Dementia with Lewy bodies. Improving diagnostic criteria. Neurology 2003, 60, 1571-1572.
  • McKeith IG, Mosimann UP. Dementia with Lewy bodies and Parkinson's disease dementia - two synucleinopathies. Advances in Clinical Neurosciences and Rehabilitation 2003, 3(3), 8-10.
  • McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O'Brien JT. Dementia with Lewy bodies. Seminars in Clinical Neuropsychiatry 2003, 8(1), 46-57.
  • Burn DJ, McKeith IG. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Movement Disorders 2003, 18(6), S72-S79.
  • Pakrasi S, Mukaetova-Ladinska EB, McKeith IG, O'Brien JT. Clinical predictors of response to Acetyl Cholinesterase Inhibitors: experience from routine clinical use in Newcastle. International Journal of Geriatric Psychiatry 2003, 18(10), 879-886.
  • Perry E, McKeith I, Ballard C. Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies. Neurology 2003, 60(11), 1852-1853.
  • Cousins DA, Burton EJ, Burn D, Gholkar A, McKeith IG, O'Brien JT. Atrophy of the putamen in dementia Lewy bodies but not Alzheimer's disease - An MRI study. Neurology 2003, 61(9), 1191-1195.
  • Karas GB, Burton EJ, Rombouts SARB, Van Schijndel RA, O'Brien JT, Scheltens P, McKeith IG, Williams D, Ballard C, Barkhof F. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. NeuroImage 2003, 18(4), 895-907.
  • Aarsland D, Ballard C, Larsen JP, McKeith I, O'Brien J, Perry R. [abstract] Marked neuroleptic sensitivity in dementia with Lewy bodies and Parkinson's disease. Nordic Journal of Psychiatry 2003, 57(2), 94.
  • Barber R, McKeith I, Ballard C, O'Brien J. Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Journal of Neurology, Neurosurgery and Psychiatry 2002, 72(3), 406-407.
  • Wesnes KA, McKeith IG. The utility of attention measurement in evaluating therapeutic responses, in cholinergic dementias [abstract]. American Journal of Geriatric Psychiatry 2002, 10(2, s1), 94.
  • Wesnes K, McKeith I, Ferrara R, Emre M, Spiegel R. Predicting response to rivastigmine in dementia with Lewy Bodies [abstract]. European Neuropsychopharmacology 2002, 12(s3), S373.
  • Burton EJ, Karas G, Paling SM, Barber R, Williams ED, Ballard CG, McKeith IG, Scheltens P, Barkhof F, O'Brien JT. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. NeuroImage 2002, 17(2), 618-630.
  • Burns A, McKeith IG. Old age psychiatry. British Journal of Psychiatry 2002, 180, 97-98.
  • Husain MM, Cummings JL, Doraiswamy MP, McKeith IG. Neurobiology of behavioral disturbances in dementia: Implications for clinical practice [abstract]. American Journal of Geriatric Psychiatry 2002, 10(2, s1), 23.
  • Burn DJ, McKeith IG. Hallucinations in patients with parkinsonism: Clinical features and management. Geriatrics and Aging 2002, 5, 22-26.
  • Ballard CG, Aarsland D, McKeith I, O'Brien J, Gray A, Cormaak F, Burn D, Cassidy T, Starfeldt R, Larsen J-P, Brown R, Tovee M. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002, 59(11), 1714-1720.
  • Wesnes KA, McKeith IG, Ferrara R, Emre M, Del Ser T, Spano PF, Cicin-Sain A, Anand R, Spiegel R. Effects of rivastigmine on cognitive function in dementia with Lewy bodies: A randomised placebo-controlled international study using the Cognitive Drug Research computerised assessment system. Dementia and Geriatric Cognitive Disorders 2002, 13(3), 183-192.
  • Ballard CG, Court JA, Piggott M, Johnson M, O'Brien J, McKeith I, Holmes C, Lantos P, Jaros E, Perry R, Perry E. Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex. Consciousness and Cognition 2002, 11(3), 461-474.
  • Walker Z, Costa DC, Walker RWH, Shaw K, Gacinovic S, Stevens T, Livingston G, Ince P, McKeith IG, Katona CLE. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. Journal of Neurology, Neurosurgery and Psychiatry 2002, 73(2), 134-140.
  • McKeith IG. Dementia with Lewy bodies. British Journal of Psychiatry 2002, 180(2), 144-147.
  • Leverenz JB, McKeith IG. Dementia with Lewy bodies. Medical Clinics of North America 2002, 86(3), 519-535.
  • SantaCruz KS, Walker Z, Swagerty D, Piggott MA, Ryo-Yang M, McKeith IG, Raghavan R, Jaros E, Perry RH. Clinical presentations in monozygotic twins with dementia with Lewy bodies. Journal of the American Medical Directors Association 2002, 3(3), 175-179.
  • Singleton AB, Wharton A, O'Brien KK, Walker MP, McKeith IG, Ballard CG, O'Brien J, Perry RH, Ince PG, Edwardson JA, Morris CM. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders 2002, 14(3-4), 167-175.
  • Colloby SJ, Fenwick JD, Williams ED, Paling SM, Lobotesis K, Ballard C, McKeith I, O'Brien JT. A comparison of Tc-99m-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. European Journal of Nuclear Medicine and Molecular Imaging 2002, 29(5), 615-622.
  • McKeith IG. [abstract] Diagnosis and treatment of dementia with Lewy Bodies: State of the art. American Journal of Geriatric Psychiatry 2002, 10(2, s1), 24.
  • Ballard C, O'Brien J, Morris CM, Barber R, Swann A, Neill D, McKeith I. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. International Journal of Geriatric Psychiatry 2001, 16(5), 499-503.
  • Ballard CG, O'Brien JT, Swann AG, Thompson P, Neill D, McKeith IG. The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: Persistence and new cases over 1 year of follow-up. Journal of Clinical Psychiatry 2001, 62(1), 46-49.
  • Ballard C, Walker M, O'Brien J, Rowan E, McKeith I. The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry 2001, 16(5), 494-498.
  • Reading PJ, Luce AK, McKeith IG. Rivastigmine in the treatment of parkinsonian psychosis anti cognitive impairment: Preliminary findings from an open trial. Movement Disorders 2001, 16(6), 1171-1174.
  • O'Brien JT, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, Gholkar A, Crum WR, Rossor MN, Fox NC. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 2001, 56(10), 1386-1388.
  • Esiri MM, Matthews F, Brayne C, Ince PG, Matthews FE, Xuereb JH, Broome JC, McKenzie J, Rossi M, McKeith IG, Lowe J, Morris JH, Neuropathology Grp Med Res Council. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001, 357(9251), 169-175.
  • Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O'Brien JT. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001, 56(5), 643-649.
  • Singleton AB, Gibson AM, McKeith IG, Ballard CG, Edwardson JA, Morris CM. Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neuroscience Letters 2001, 303(1), 33-36.
  • Kalaria RN, Ballard CG, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA. Multiple substrates of late-onset dementia: Implications for brain protection. Ageing Vulnerability: Causes and Interventions: Novartis Foundation Symposium 235 2001, 235, 49-65.
  • Kalaria RN, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA. Multiple substrates of late-onset dementia: implications for brain protection. Ageing Vulnerability: Causes and Interventions: Novartis Foundation Symposium 235 2001, 235, 49-65.
  • Grace J, Daniel S, Stevens T, Shankar KK, Walker Z, Byrne EJ, Butler S, Wilkinson D, Woolford J, Waite J, McKeith IG. Long-term use of rivastigmine in patients with dementia with Lewy bodies: An open-label trial. International Psychogeriatrics 2001, 13(2), 199-205.
  • Luce A, McKeith I, Swann A, Daniel S, OBrien J. How do memory clinics compare with traditional old age psychiatry services?. International Journal of Geriatric Psychiatry 2001, 16(9), 837-845.
  • Lloyd AJ, Grace JB, Jaros E, Perry RH, Fairbairn AF, Swann AG, O'Brien JT, McKeith IG. Depression in late life, cognitive decline and white matter pathology in two clinico-pathologically investigated cases. International Journal of Geriatric Psychiatry 2001, 16(3), 281-287.
  • Barber R, Panikkar A, McKeith IG. Dementia with Lewy bodies: diagnosis and management. International Journal of Geriatric Psychiatry 2001, 16(1), S12-S18.
  • Middelkoop HAM, Van Der Flier WM, Burton EJ, Lloyd AJ, Paling S, Barber R, Ballard C, McKeith IG, O'Brien JT. Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology 2001, 57(11), 2117-2120.
  • Aarsland D, Ballard C, McKeith I, Perry RH, Larsen JP. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences 2001, 13(3), 374-379.
  • Ballard C, O'Brien J, Gray A, Cormack F, Ayre G, Rowan E, Thompson P, Bucks R, McKeith I, Walker M, Tovee M. Attention and fluctuating attention in patients with dementia with lewy bodies and alzheimer disease. Archives of Neurology 2001, 58(6), 977-982.
  • Barber R, McKeith IG, Ballard C, Gholkar A, O'Brien JT. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: Magnetic resonance imaging volumetric study. Dementia and Geriatric Cognitive Disorders 2001, 12(3), 198-205.
  • Aarsland D, Ballard C, Larsen JP, McKeith I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. International Journal of Geriatric Psychiatry 2001, 16(5), 528-536.
  • Ballard C, OBrien JT, Swann A, Thompson P, Neill D, McKeith I. The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease. Journal of Clinical Psychiatry 2000, 62, 46-49.
  • Shikiar R, Shakespeare A, Sagnier PP, Wilkinson D, McKeith I, Dartigues JF, Dubois B. The impact of metrifonate therapy on caregivers of patients with Alzheimer's disease: Results from the MALT clinical trial. Metrifonate in Alzheimer's Disease Trial. Journal of the American Geriatrics Society 2000, 48(3), 268-274.
  • Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale - Two methods to assess fluctuating confusion in dementia. British Journal of Psychiatry 2000, 177, 252-256.
  • Xu WM, Liu LZ, Emson P, Harrington CR, McKeith IG, Perry RH, Morris CM, Charles IG. The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies. Neuroreport 2000, 11(2), 297-299.
  • McKeith IG, Burn D. Spectrum of Parkinson's disease, Parkinson's dementia, and lewy body dementia. Neurologic Clinics 2000, 18(4), 865-883.
  • McKeith IG, Grace JB, Walker Z, Byrne EJ, Wilkinson D, Stevens T, Perry EK. Rivastigmine in the treatment of dementia with Lewy bodies: Preliminary findings from an open trial. International Journal of Geriatric Psychiatry 2000, 15(5), 387-392.
  • McKeith IG. Regulatory issues concerning behavioral and psychological symptoms of dementia in Europe. International Psychogeriatrics 2000, 12, 321-326.
  • Walker MP, Ayre GA, Perry EK, Wesnes K, McKeith IG, Tovee M, Edwardson JA, Ballard CG. Quantification and characterisation of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2000, 11(6), 327-335.
  • O'Brien JT, Paling S, Barber R, Ballard C, McKeith I. Progressive brain atrophy on serial MRI in dementia with Lewy bodies: A comparison with Alzheimer's disease and vascular dementia. Neurobiology of Aging 2000, 21(1S), S130.
  • Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK. Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 2000, 98(1), 79-87.
  • Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry 2000, 15(10), 911-916.
  • Chinnery PF, Taylor GA, Howell N, Andrews RM, Morris CM, Taylor RW, McKeith IG, Perry RH, Edwardson JA, Turnbull DM. Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology 2000, 55(2), 302-304.
  • O'Brien JT, Metcalfe S, Swann A, Hobson J, Jobst K, Ballard C, McKeith I, Gholkar A. Medial temporal lobe width on CT scanning in Alzheimer's disease: Comparison with vascular dementia, depression and dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders 2000, 11(2), 114-118.
  • Ballard CG, McKeith IG, Ayre G, Gray A, Cormack F, Tovee M, O'Brien JT, Walker MP. Impairments in attention and fluctuating attention distinguish between dementia with Lewy bodies and Alzheimer's disease. Neurology 2000, 54(3), A451.
  • McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Cicin-Sain A, Ferrara R, Spiegel R. Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study. Lancet 2000, 356(9247), 2031-2036.
  • Del Ser T, McKeith I, Anand R, Cicin-Sain A, Ferrara R, Spiegel R. Dementia with Lewy bodies: Findings from an international multicentre study. International Journal of Geriatric Psychiatry 2000, 15(11), 1034-1045.
  • Ballard C, Piggott M, Johnson M, Cairns N, Perry R, McKeith I, Jaros E, O'Brien J, Holmes C, Perry E. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Annals of Neurology 2000, 48(6), 868-876.
  • Harrington F, Saxby BK, McKeith IG, Wesnes K, Ford GA. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000, 36(6), 1079-1082.
  • Harrington F, Saxby BK, McKeith IG, Wesnes K, Ford GA. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000, 36(6), 1079-1082.
  • McKeith IG. Clinical Lewy body syndromes. Annals of the New York Academy of Science: Molecular Basis of Dementia 2000, 920, 1-8.
  • Shaw FE, Richardson DA, Steen IN, McKeith IG, Bond J, Kenny RA. Clinical characteristics of fallers with cognitive impairment and dementia who comply with multi-disciplinary post-fall intervention. Age and Ageing 2000, 29(s2), A22.
  • Shaw FE, Richardson DA, Dawson P, Steen IN, McKeith IG, Bond J, Kenny RA. Can multi-disciplinary intervention prevent falls in patients with cognitive impairment and dementia attending a casualty department?. Irish Journal of Medicine 2000, 169(2), 30.
  • Grace JB, Walker MP, McKeith IG. A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry 2000, 15(11), 1028-1033.
  • Ballard CG, Ayre G, O'Brien J, Sahgal A, McKeith IG, Ince PG, Perry RH. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dementia and Geriatric Cognitive Disorders 1999, 10(2), 104-108.
  • Ballard C, Holmes C, McKeith I, Neill D, O'Brien J, Cairns N, Lantos P, Perry E, Ince P, Perry R. Psychiatric morbidity in dementia with Lewy bodies: A prospective clinical and neuropathological comparative study with Alzheimer's disease. American Journal of Psychiatry 1999, 156(7), 1039-1045.
  • Whitworth A, Lesser R, McKeith I. Profiling conversation in Parkinson's disease with cognitive impairment. Aphasiology 1999, 13(4-5), 407-425.
  • Walker Z, Grace J, Overshot R, Satarasinghe S, Swan A, Katona CLE, McKeith IG. Olanzapine in dementia with Lewy bodies: A clinical study. International Journal of Geriatric Psychiatry 1999, 14(6), 459-466.
  • Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, Kerwin R, Perry R, Perry E. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. Journal of Neurochemistry 1999, 73(4), 1590-1597.
  • Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999, 52(6), 1153-1158.
  • Walker Z, Costa DC, Ince P, McKeith IG, Katona CLE. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet 1999, 354(9179), 646-647.
  • Briel RCG, McKeith IG, Barker WA, Hewitt Y, Perry RH, Ince PG, Fairbairn AF. EEG findings in dementia with Lewy bodies and Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1999, 66(3), 401-403.
  • McKeith I, O'Brien J. Dementia with Lewy bodies. Australian and New Zealand Journal of Psychiatry 1999, 33(6), 800-808.
  • Atkinson A, Singleton AB, Steward A, Ince PG, Perry RH, McKeith IG, Fairbairn AF, Edwardson JA, Daly AK, Morris CM. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease. Pharmacogenetics and Genomics 1999, 9(1), 31-36.
  • Chapman FM, Dickinson J, McKeith I, Ballard C. Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: Treatment implications. American Journal of Psychiatry 1999, 156(12), 1983-1985.
  • Dubois B, McKeith I, Orgogozo JM, Collins O, Meulien D, Malt Study Grp. A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: The malt study. International Journal of Geriatric Psychiatry 1999, 14(11), 973-982.
  • McKeith IG, Ince P, Jaros EB, Fairbairn A, Ballard C, Grace J, Morris CM, Perry RH. What are the relations between Lewy body disease and AD?. Journal of Neural Transmission Supplement 1998, (54), 107-116.
  • McGee MA, Johnson AL, Kay DWK, Med Res Council Cognitive Function Ageing Study, (Bond J, Gregson B, Hrisos S, McKeith I). The description of activities of daily living in five centres in England and Wales. Age and Ageing 1998, 27(5), 605-613.
  • Perry RH, McKeith IG, Perry EK. Lewy body dementia. Neuroscience News 1998, 1(3), 28-35.
  • Ballard C, Shaw F, McKeith I, Kenny R. High prevalence of neurovascular instability in neurodegenerative dementias. Neurology 1998, 51(6), 1760-1762.
  • Ballard CG, McKeith I, Harrison R, O'Brien J, Adams R, Lowery K, Perry R, Ince P. Depression in dementia with Lewy bodies and Alzheimer's disease. Journal of Affective Disorders 1998, 27, 631-636.
  • MRC CFAS Medical Research Council Cognitive Function & Ageing Study, (McKeith I), (Hrisos S), (Bond J). Cognitive function and dementia in six areas of England and Wales: The distribution of MMSE and prevalence of GMS organicity level in the MRC CFA Study. Psychological Medicine 1998, 28(2), 319-35.
  • Lamb H, Christie J, Singleton AB, Leake A, Perry RH, Ince PG, McKeith IG, Melton LM, Edwardson JA, Morris CM. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies - Distinctions between diseases. Neurology 1998, 50(2), 388-391.
  • Singleton AB, Lamb H, Leake A, McKeith IG, Perry RH, Morris CM. No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease. Neuroscience Letters 1997, 234(1), 19-22.
  • Singleton AB, Lamb H, Leake A, McKeith IG, Ince PG, Perry RH, Morris CM. No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies. NeuroReport 1997, 8(16), 3637-3639.
  • Christie J, Lamb H, Singleton AB, Leake A, Melton LS, Perry RH, McKeith IG, Morris CM. Determination of the alpha-1 anti-chymotrypsin polymorphism in Alzheimer's disease. Alzheimer's Research 1996, 2, 201-204.
  • Burns A, Perry EK, McKeith IG. Correlation of cholinergic abnormalities with senilee plaques and mental test scores in senile dementia. International Journal of Geriatric Psychiatry 1996, 11(9), 765-771.
  • Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology. Neuroscience 1995, 64(2), 385-395.
  • McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). British Journal of Psychiatry 1994, 165, 324-332.
  • Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Honavar M, Dean A, Griffiths M, McKeith IG, Perry RH. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. NeuroReport 1994, 5(7), 747-749.
  • Marshall EF, Perry EK, Perry RH, McKeith IG, Fairbairn AF, Thompson P. Dopamine metabolism in postmortem caudate-nucleus in neurodegenerative disorders. Neuroscience Research Communications 1994, 14(1), 17-25.
  • Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 1994, 343(8912), 1565-1565.
  • McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, Perry RH. An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994, 44(5), 872-877.
  • Perry EK, Marshall E, Thompson P, McKeith IG, Collerton D, Fairbairn AF, Ferrier IN, Irving D, Perry RH. Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 1993, 6(3), 167-177.
  • Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, Fairbairn AF, Ince PG, Morris CM, Cheng AV, Perry RH. Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia: Similarity to Parkinson's and Distinction from Alzheimer Disease. Alzheimer Disease & Associated Disorders 1993, 7(2), 69-79.
  • Jabeen S, McKeith IG, Fairbairn AF, Perry RH, Ferrier IN. Psychotic Symptoms in Alzheimer’s Disease. International Journal of Geriatric Psychiatry 1992, 7(5), 341-345.
  • McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychological Medicine 1992, 22(4), 911-922.
  • McKeith I, Fairbairn A, Perry RH, Thompson P, Perry EK. Neuroleptic Sensitivity in Patients with Senile Dementia of Lewy Body Type. BMJ 1992, 305(6855), 673-678.
  • McKeith IG, Fairbairn AF, Perry RH. Clinical Diagnostic-Criteria for Lewy Body Dementia. Dementia 1992, 3(4), 251-252.
  • Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, Edwardson JA, Ince P, Blessed G, Irving D, Perry RH. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Annals of the New York Academy of Sciences 1991, 640, 197-202.
  • Leake A, Perry EK, Perry RH, Jabeen S, Fairbairn AF, McKeith IG, Ferrier IN. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations. Biological Psychiatry 1991, 29(4), 357-364.
  • Cheng AVT, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG, Edwardson JA, Perry RH, Perry EK. Cortical serotonin-S₂ receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences 1991, 106(1), 50-55.
  • Ferrier IN, Perry RH, Fairbairn AF, McKeith IG, Leake A, Yates M. Post-mortem investigation of neurochemical and neuro-peptidergic hypothesis of depression. Psychopharmacology 1988, 96(1 (suppl.)), 98-98.
  • McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D. 5-HT receptor binding in post-mortem brain from patients with affective disorder. Journal of Affective Disorders 1987, 13(1), 67-74.
  • Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 1978, 2(6150), 1457-1459.

• Authored Book

  • Perry RH, McKeith IG, Perry EK. Dementia with Lewy Bodies : Clinical, Pathological and Treatment Issues. Cambridge: Cambridge University Press, 1996.

• Book Chapters

  • McKeith IG. Dementia with lewy bodies: A clinical overview. In: Ames, D; O'Brien, JT; Burns, A, ed. Dementia. Boca Raton, FL, USA: CRC Press, 2017, pp.703-713.
  • McKeith IG. Clinical diagnostic criteria for dementia with Lewy bodies. In: Kosaka K, ed. Dementia with Lewy Bodies: Clinical and Biological Aspects. Tokyo: Springer Japan, 2016, pp.59-71.
  • Taylor J-P, McKeith IG. The Lewy Body Dementia Spectrum (Alpha Synucleinopathies). In: Abou-Saleh, M.M., Katona, C.L.E., Kumar, A, ed. Principles and Practice of Geriatric Psychiatry. Chichester, UK: Wiley-Blackwell, 2011, pp.chapter 58.
  • Perry EK, Piggott MA, Johnson M, Ballard CG, McKeith IG, Burn DJ. Neurotransmitter correlates of neuropsychiatric symptoms in dementia with Lewy bodies. In: Bédard, M.-A, ed. Mental & Behavioural Dysfunction in Movement Disorders. Totowa, New Jersey, USA: Humana Press Inc, 2002, pp.285-294.
  • Perry EK, Burn DJ, McKeith IG, O'Brien J, Perry R. Lewy body diseases. In: Davis, K.L., Charney, D., Coyle, J.T., Nemeroff, C, ed. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia: Lippincott Williams & Wilkins, 2002, pp.1301-1316.
  • Perry EK, Perry RH, McKeith IG, Piggott MA, Smith P, Marshall E. Clinical, pathological and neurochemical characteristics of Lewy body dementia. In: Alzheimer's and Parkinson's Diseases: Recent Developments. Springer US, 1995, pp.77-86.

• Conference Proceedings (inc. Abstracts)

  • Cromarty R, Graziadio S, Colloby S, Killen A, Peraza LR, Elder G, Firbank M, Thomas A, McKeith I, O'Brien J, Taylor J-P. Electrophysiological Correlates of Attentional Dysfunction in Dementia with Lewy Bodies. In: International Dementia with Lewy Bodies Conference 2015. 2015, Ft. Lauderdale, FL, USA: American Journal of Neurodegenerative Disease.
  • Murphy N, Killen A, Graziadio S, Peraza LR, Firbank M, Baker M, Elder G, Thomas A, McKeith I, Rochester L, Taylor J-P. Early Bottom-Up Visual Information Processing in Hallucinating Patients with Parkinson’s Disease with Dementia: A Preliminary Visual Evoked Potential Study. In: International Dementia with Lewy Bodies Conference 2015. 2015, Ft. Lauderdale, FL, USA: American Journal of Neurodegenerative Disease.
  • Peraza LR, Colloby S, Firbank M, McKeith I, O'Brien J, Thomas A, Taylor J-P. Dementia with Lewy Bodies and Parkinson’s Disease Dementia Show No differences in Resting State Functional MRI. In: International Dementia with Lewy Bodies Conference 2015. 2015, Ft. Lauderdale, FL, USA: American Journal of Neurodegenerative Disease.
  • Blanc F, Thomas A, Donaghy P, Bousiges O. Cortical thickness in dementia with Lewy bodies and Alzheimer's disease: A comparison of prodromal and dementia stages. In: 17th IPA International Conference: Balancing Cure with Care - Advances in Late Life Mental Health. 2015, Berlin, Germany: Cambridge University Press.
  • McKeith IG. The spectrum of dementia with Lewy bodies (DLB)-prodromal to end-stage. In: 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. 2014, Geneva, Switzerland: Elsevier.
  • O'Brien JT, Oertel WH, McKeith IG, Grosset DG, Walker Z, Tatsch K, Tolosa E, Sherwin PF, Grachev ID. Diagnostic performance of ioflupane I123 injection (DaTSCAN™ Normal 0 false false false EN-GB X-NONE X-NONE ) in patients with movement disorders and dementia. In: Joint Congress of European Neurology. 2014, Istanbul, Turkey: Springer.
  • O'Brien JT, Oertel WH, McKeith IG, Grosset DG, Walker Z, Tatsch K, Tolosa E, Sherwin PF, Grachev ID. Diagnostic performance of ioflupane I123 injection (DaTSCAN) in patients with movement disorders and dementia. In: 18th International Congress of Parkinson's Disease and Movemenet Disorders. 2014, Stockholm, Sweden: John Wiley & Sons, Inc.
  • Tatsch K, Grachev I, O'Brien J, McKeith I, Walker Z, Tolosa E, Sherwin P, Oertel W, Grosset D. [123I]FP-CIT (DaTscan; Ioflupane I123 Injection) SPECT brain imaging - Diagnostic effectiveness in patients with movement disorders and/or dementia. In: SNMMI 2014 Annual Meeting. 2014, St. Louis, MO: Society of Nuclear Medicine.
  • Taylor JP, Colloby SJ, McKeith IG, O'Brien JT. Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in Dementia with Lewy bodies. In: Towards Successful Aging: Harmony of Mental, Physical and Social Life, 16th International Conference. 2013, Seoul, Korea: Cambridge University Press.
  • McKeith IG. Early diagnosis for Lewy Body Disease and treatment. In: 12th International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. 2012, Stockholm, Sweden: Elsevier Inc.
  • Collerton D, Collerton J, Jagger J, Bond J, Saxby BK, Brooker H, McKeith IG, Kirkwood T. Cognitive Performance in a UK Cohort of 85 Year Olds: The Newcastle 85+ Study. In: Journal of Psychophysiology: International Conference “Aging & Cognition”. 2011, Dortmund, Germany: Hogrefe Publishing Corp.
  • Religa D, Johnson M, Kalaria R, Jaros E, McKeith IG, Perry R, Court JA, Naslund J, Perry EK. Decreased levels of amyloid beta peptide in the brains of smokers. In: European Journal of Neurology: 9th Congress of the EFNS. 2005, Athens, Greece: Wiley-Blackwell Publishing Ltd.
  • Colloby SJ, Fenwick JD, Paling S, Lobotesis K, Ballard C, McKeith I, Williams ED, O'Brien JT. Tc-99m-HMPAO SPECT image analysis in dementia with Lewy bodies and Alzheimer's disease using Statistical Parametric Mapping. In: 2nd Meeting of the Alzheimers Imaging Consortium. 2004, Stockholm, Sweden: Neurobiology of Aging: Elsevier.
  • Rowan EN, Saxby BK, Askew KA, Thomas AJ, Manktelow TC, Wesner LA, McKeith IG. Improved attentional performance in DLB and PDD following donepezil treatment. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2004, Harrogate, UK: Sage Publications Ltd.
  • O'Brien JT, Colloby S, Pakrasi S, Burn D, Williams D, Wyper D, Owens J, McKeith I. I-123-QNB SPECT demonstrates loss of cholinergic muscarinic receptors in Alzheimer's disease, but occipital increases in dementia with lewy bodies and Parkinson's disease dementia. In: Neurobiology of Aging: 9th International Conference on Alzheimers Disease and Related Disorders. 2004, Philadelphia, Pennsylvania, USA: Elsevier Inc.
  • McKeith IG, Mosimann UP. Dementia with Lewy bodies and Parkinson's disease. In: 8th International Symposium on the Treatment of Parkinsons Disease. 2004, Kobe, Japan: Parkinsonism & Related Disorders: Elsevier.
  • Burton EJ, Karas G, Paling SM, Williams ED, Ballard CG, McKeith IG, Scheltens P, Barkhof F, O'Brien JT. Cerebral atrophy in dementia with Lewy bodies studied using voxel-based morphometry. In: 2nd Meeting of the Alzheimers Imaging Consortium. 2004, Stockholm, Sweden: Neurobiology of Aging: Elsevier.
  • Molloy S, O'Brien JT, McKeith IG, Burn DJ. Can parkinsonian phenotype be used to predict levodopa response in extrapyramidal syndromes with and without dementia?. In: Journal of Neurology, Neurosurgery and Psychiatry: Spring Meeting of the Association of British Neurologists. 2004, London, UK: BMJ Group.
  • Saxby R, Harrington F, McKeith IG, Wesnes KA, Ford GA. The effect of candesartan on cognitive function in older adults with mild hypertension. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2003, Cambridge, UK: Sage Publications Ltd.
  • Saxby BK, Harrington F, McKeith IG, Wesnes K, Ford GA. The effect of candesartan cilexetil on cognitive function in older adults with mild hypertension. In: Journal of Hypertension: 13th European Meeting on Hypertension. 2003, Milan, Italy: Lippincott Williams & Wilkins.
  • Allan LM, McLaren AT, Allen J, Ballard CG, McKeith IG, Murray A, Kenny RA. Heart rate variability is reduced in dementia with Lewy bodies but not Alzheimer’s disease or vascular dementia. In: First Congress of the International Society for Vascular Behavioural and Cognitive Disorders (VAS-COG). 2003, Gothenburg, Sweden.
  • Vanoli A, McNamee P, Hutchings D, Steen N, Brotherton S, McKeith I, Bond J. An economic approach to the measurement of benefits of cholinesterase inhibitors in Alzheimer's disease. In: 32nd Annual Conference of the British Society of Gerontology. 2003, Newcastle upon Tyne, UK.
  • Grace JB, McKeith IG, Wesnes K. A comparison of the use of carers' diaries and a computerised test battery to measure the fluctuations in patients with lewy bodies (DLB). In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2003, Cambridge, UK: Sage Publications Ltd.
  • Johnson M, Court J, Perry E, Kalaria R, McKeith I, Jaros E, Perry R, Naslund J, Religa D. Tobacco use is associated with attenuation of beta-amyloidosis in hippocampus and entorhinal cortex of normal elderly individuals. In: Neurobiology of Aging. 2002, Elsevier Inc.
  • Colloby S, Paling SM, Lobotesis K, Ballard C, McKeith IG, O'Brien JT, Fenwick JD, Williams ED. Tc-99m HMPAO SPECT image analysis in dementia with Lewy bodies and Alzheimer's disease using statistical paramentric mapping. In: Neurobiology of Aging. 2002, Elsevier Inc.
  • Lloyd AJ, McGuckin EA, Barnett NA, Gholkar A, McKeith IG, Young AH, Ferrier IN, O'Brien JT. Increased salivary cortisol in late- but not early-onset depression: Relationship with hippocampal volume. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2002, Harrogate: Sage Publications Ltd.
  • Wilkinson L, Daniel S, Newby J, Thomas A, Sanders J, Myint P, Richardson J, McKeith I. Donepezil treatment and withdrawal in patients with dementia with lewy bodies (DLB) and patients with Parkinsons disease plus DLB. In: Neurobiology of Aging. 2002, Elsevier Inc.
  • Perry EK, Piggott MA, Johnson M, Ballard CG, McKeith IG, Jaros E, Perry RH. Cholinergic and monoaminergic correlates of clinical symptoms in dementia with Lewy bodies. In: Mapping the Progress of Alzheimer's and Parkinson's Disease. 2002, Kyoto, Japan: Springer.
  • Burton EJ, Paling SM, Ballard CG, McKeith IG, O'Brien JT, Karas G, Scheltens P, Barkhof F, Williams ED. Cerebral atrophy in dementia with Lewy bodies studied using voxel-based morphometry. In: Neurobiology of Aging. 2002, Elsevier Inc.
  • Ballard C. Visual hallucinations in dementia. In: Annual Meeting of the British Neuropsychiatry Association. 2001, London, UK: BMJ Group.
  • Williams ED, Colloby SJ, Paling SM, Lobotesis K, Fenwick JD, Ballard C, McKeith I, O'Brien JT. Dementia with Lewy bodies differentiated from Alzheimer's disease on Tc-99m-HMPAO SPECT using statistical parametric mapping. In: European Journal of Nuclear Medicine. 2001.
  • Paling S, Williams ED, LLoyd A, Barber R, Burton EJ, Gholkar A, Crum WR, Fox NC, McKeith I, Ballard C, O'Brien JT. Serial MR image registration and analysis techniques applied to studies of differential cerebral atrophy in late-onset dementia. In: International Conference on Mathematics and Engineering Techniques in Medicine and Biological Sciences. 2000, Las Vegas, Nevada, USA: CSREA PRESS.
  • Shaw FE, Richardson DA, Steen IN, McKeith IG, Bond J, Kenny RA. Predictors of further falls in patients with cognitive impairment and dementia attending an accident and emergency facility. In: American Geriatrics Society/AFAR 2000 Annual Scientific Meeting. 2000, Nashville, TN: Wiley-Blackwell Publishing Ltd.
  • Shaw FE, Richardson DA, Steen IN, Mckeith IG, Bond J, Kenny RA. Predictors of further falls in patients with cognitive impairment and dementia attending an accident and emergency facility. In: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2000.
  • Shaw FE, Richardson DA, Steen IN, McKeith IG, Bond J, Kenny RA. Longer term health and social outcomes in patients with cognitive impairment and dementia who attend the casualty department with a fall. In: Communications to the Spring Meeting of the British Geriatrics Society. 2000, Warwick: Oxford University Press.
  • Shaw FE, Richardson DA, Steen IN, Vanoli A, Mckeith IG, Bond J, Kenny RA. Health care implications of falls in patients with cognitive impairment and dementia attending an accident and emergency facility. In: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2000.
  • Shaw FE, Richardson DA, Dawson P, Steen IN, McKeith IG, Bond J, Kenny RA. Can multi-disciplinary intervention prevent falls in patients with cognitive impairment and dementia attending an accident and emergency facility?. In: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2000.
  • Shaw FE, Richardson DA, Dawson P, Steen IN, McKeith IG, Bond J, Kenny RA. Can multi-disciplinary intervention prevent falls in patients with cognitive impairment and dementia attending a casualty department?. In: British Geriatrics Society Communications to the Autumn Meeting 1999. 2000, London: Oxford University Press.
  • McKeith IG. Behavioral and psychological symptoms of dementia and dementia with Lewy bodies. In: International Psychogeriatrics. 2000, Cambridge University Press.
  • McKeith IG, Perry EK, Perry RH, and for the Consortium on Dementia with Lewy Bodies. Report of the second dementia with Lewy body international workshop - Diagnosis and treatment. In: Second International Workshop of the Consortium on Dementia with Lewy Bodies. 1999, Newcastle upon Tyne.
  • Perry E, Grace J, Perry R, McKeith I. Cholinergic mechanisms of psychosis and clinical efficacy of cholinergic drugs. In: 40th Annual Meeting of the Scandinavian Society for Psychopharmacology. 1999, Copenhagen, Denmark: Informa Healthcare.
  • Shaw FE, Richardson DA, Bond J, McKeith IG, Kenny RA. Clinical characteristics of patients with cognitive impairment and dementia attending an accident and emergency facility with falls. In: Journal of the American Geriatrics Society. 1998, Wiley-Blackwell Publishing, Inc.
  • Perry RH, McKeith IG, Perry EK. Lewy body dementia: clinical, pathological and neurochemical interconnections. In: Journal of Neural Transmission: Dementia in Parkinsonism. 1997, London: Springer Wien.
  • Perry R, McKeith I, Perry E. Lewy body dementia - clinical, pathological and neurochemical interconnections. In: Dementia in Parkinsonism: Meeting of the European Brain Bank Network. 1997, London: Springer Wien.

• Editorials

  • McKeith I. Dementia in Parkinson's disease: common and treatable. Lancet Neurology 2004, 3(8), 456-456.
  • McKeith IG, Masterman DL, Farlow MR, Grossberg GT. Future trends in cholinergic therapy. Geriatrics 2003, 58(s6), i-iv.
  • McKeith I. Galantamine for vascular dementia. Lancet Neurology 2002, 1(4), 210-210.
  • Hogan DB, McKeith IG. Of MCI and dementia: Improving diagnosis and treatment. Neurology 2001, 56(9), 1131-1132.
  • McKeith IG, O'Brien JT, Ballard C. Diagnosing dementia with Lewy bodies. Lancet 1999, 354(9186), 1227-1228.

• Letters

  • Thomas AJ, Attems J, Colloby SJ, O'Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Author response: Autopsy validation of 123 I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 2017, 89(7), 751-751.
  • Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R. Elderly Individuals With FTLD [Reply]. JAMA Neurology 2013, 70(3), 412-413.
  • McKeith I. Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome: Some comments. International Psychogeriatrics 2010, 22(4), 680.
  • Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, Williams ED, McKeith IG, O'Brien JT. The effects of donepezil on nicotinic receptor status in dementia: A ¹²³I-5IA-85380 SPECT study. Journal of Neurology, Neurosurgery and Psychiatry 2008, 79(4), 485-487.
  • McKeith IG, Morris CM. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996, 347(9017), 1775-1775.
  • Piggott MA, Perry EK, McKeith IG, Marshall E, Perry RH. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 1994, 343(8904), 1045-1045.
  • MCKEITH IG, WILLIAMS A, NICOL AR. CLONIDINE IN TOURETTE SYNDROME. LANCET 1981, 1(8214), 270-271.

• Notes

  • Killen A, Olsen K, McKeith IG, Thomas AJ, O'Brien JT, Donaghy P, Taylor J-P. The challenges of COVID-19 for people with dementia with Lewy bodies and family caregivers. International Journal of Geriatric Psychiatry 2020, 35(12), 1431-1436.
  • McKeith IG. Author response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2018, 90(6), 301-301.
  • Ziabreva I, Ballard CG, Aarsland D, Larsen JP, McKeith IG, Perry RH, Perry EK. Lewy body disease: Thalamic cholinergic activity related to dementia and parkinsonism. Neurobiology of Aging 2006, 27(3), 433-438.

• Reviews

  • Outeiro TF, Alcalay RN, Antonini A, Attems J, Bonifati V, Cardoso F, Chesselet M-F, Hardy J, Madeo G, McKeith I, Mollenhauer B, Moore DJ, Rascol O, Schlossmacher MG, Soreq H, Stefanis L, Ferreira JJ. Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease". Movement Disorders 2023, 38(7), 1127-1142.
  • O'Brien JT, Chouliaras L, Sultana J, Taylor J-P, Ballard C, Aarsland D, Blanc F, Boeve B, Brooks DJ, Chaudhuri KR, Cummings J, Feldman HH, Flicker L, Galvin JE, Grosset DG, Ikeda M, Kohlhaas S, Lawlor B, Lemstra AW, Leroi I, Londos E, Leverenz JB, Lewis S, McKeith I, Mills R, Oakley R, Richardson J, Sabbagh M, Skidmore J, Svennigsson P, Tiraboschi P, Weintraub D, Walker Z, Watson R, Weil RS, Williams-Gray CH, Yarnall A. RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus. Alzheimer's Research and Therapy 2022, 14(1), 169.
  • Amin J, Erskine D, Donaghy PC, Surendranathan A, Swann P, Kunicki AP, Boche D, Holmes C, McKeith IG, O'Brien JT, Teeling JL, Thomas AJ. Inflammation in dementia with Lewy bodies. Neurobiology of Disease 2022, 168, 105698.
  • Babiloni C, Arakaki X, Azami H, Bennys K, Blinowska K, Bonanni L, Bujan A, Carrillo MC, Cichocki A, de Frutos-Lucas J, Del Percio C, Dubois B, Edelmayer R, Egan G, Epelbaum S, Escudero J, Evans A, Farina F, Fargo K, Fernandez A, Ferri R, Frisoni G, Hampel H, Harrington MG, Jelic V, Jeong J, Jiang Y, Kaminski M, Kavcic V, Kilborn K, Kumar S, Lam A, Lim L, Lizio R, Lopez D, Lopez S, Lucey B, Maestu F, McGeown WJ, McKeith I, Moretti DV, Nobili F, Noce G, Olichney J, Onofrj M, Osorio R, Parra-Rodriguez M, Rajji T, Ritter P, Soricelli A, Stocchi F, Tarnanas I, Taylor JP, Teipel S, Tucci F, Valdes-Sosa M, Valdes-Sosa P, Weiergraber M, Yener G, Guntekin B. Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel. Alzheimer's and Dementia 2021, 17(9), 1528-1553.
  • Erskine D, Koss D, Korolchuk VI, Outeiro TF, Attems J, McKeith I. Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders. Acta Neuropathologica 2021, 141, 511-526.
  • Babiloni C, Blinowska K, Bonanni L, Cichocki A, De Haan W, Del Percio C, Dubois B, Escudero J, Fernandez A, Frisoni G, Guntekin B, Hajos M, Hampel H, Ifeachor E, Kilborn K, Kumar S, Johnsen K, Johannsson M, Jeong J, LeBeau F, Lizio R, Lopes da Silva F, Maestu F, McGeown WJ, McKeith I, Moretti DV, Nobili F, Olichney J, Onofrj M, Palop JJ, Rowan M, Stocchi F, Struzik ZM, Tanila H, Teipel S, Taylor JP, Weiergraber M, Yener G, Young-Pearse T, Drinkenburg WH, Randall F. What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons. Neurobiology of Aging 2020, 85, 58-73.
  • O'Brien J, Taylor JP, Ballard C, Barker RA, Bradley C, Burns A, Collerton D, Dave S, Dudley R, Francis P, Gibbons A, Harris K, Lawrence V, Leroi I, McKeith I, Michaelides M, Naik C, O'Callaghan C, Olsen K, Onofrj M, Pinto R, Russell G, Swann P, Thomas A, Urwyler P, Weil RS, Ffytche D. Visual hallucinations in neurological and ophthalmological disease: Pathophysiology and management. Journal of Neurology, Neurosurgery and Psychiatry 2020, 91(5), 512-519.
  • Taylor J-P, McKeith IG, Burn D, Boeve B, Weintraub D, Bamford C, Allan L, Thomas AJ, O'Brien JT. New evidence on the management of Lewy body dementia. The Lancet Neurology 2020, 19(2), 157-169.
  • McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017, 89(1), 88-100.
  • O'Brien JT, Holmes C, Jones M, Jones R, Livingston G, McKeith I, Mittler P, Passmore P, Ritchie C, Robinson L, Sampson EL, Taylor J-P, Thomas A, Burns A. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. Journal of Psychopharmacology 2017, 31(2), 147-168.
  • Donaghy PC, McKeith IG. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimer's Research & Therapy 2014, 6(4), 46.
  • Stephan BCM, Minett T, Pagett E, Siervo M, Brayne C, McKeith IG. Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review. BMJ Open 2013, 3(2), e001909.
  • Kotting P, Beicher K, McKeith IG, Rossor MN. Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network. Alzheimer's Research & Therapy 2012, 4(4), 23.
  • Sinha N, Firbank M, O'Brien JT. Biomarkers in dementia with Lewy bodies: a review. International Journal of Geriatric Psychiatry 2012, 27(5), 443-453.
  • Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. European Journal of Neurology 2007, 14(1), E1-E26.
  • Matthews FE, Stephan BC, Bond J, McKeith I, Brayne C, Medical Research Council Cognitive Function and Ageing Study. Operationalization of mild cognitive impairment: a graphical approach. PLoS Medicine 2007, 4(10), 1615-1619.
  • Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM-Y, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK. DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007, 68(11), 812-819.
  • Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M. Diagnostic procedures for Parkinson's disease dementia: Recommendations from the Movement Disorder Society Task Force. Movement Disorders 2007, 22(16), 2314-2324.
  • McKeith I. Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide. Practical Neurology 2007, 7(6), 374-382.
  • Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders 2007, 22(12), 1689-1707.
  • Burns A, O'Brien J, BAP Dementia Consensus Group:, Ford GA, McKeith IG, Thomas AJ, et al. Clinical practice with anti-dementia drugs: A consensus statement from British Association for Psychopharmacology. Journal of Psychopharmacology 2006, 20(6), 732-755.
  • Geser F, Wenning GK, Poewe W, McKeith I. How to diagnose dementia with Lewy bodies: State of the art. Movement Disorders 2005, 20(12), S11-S20.
  • McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VMY, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology 2005, 65(12), 1863-1872.
  • McKeith I, Cummings J. Behavioural changes and psychological symptoms in dementia disorders. Lancet Neurology 2005, 4(11), 735-742.
  • Court JA, Johnson M, Religa D, Keverne J, Kalaria R, Jaros E, McKeith IG, Perry R, Naslund J, Perry EK. Attenuation of A beta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking. Neuropathology and Applied Neurobiology 2005, 31(5), 522-535.
  • McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos MacHado J, O'Brien J, Playfer J, Reid W, On behalf of the International Psychogeriatric Association Expert Meeting on DLB. Dementia with Lewy bodies. Lancet Neurology 2004, 3(1), 19-28.
  • Mosimann UP, McKeith IG. Dementia with Lewy bodies - diagnosis and treatment. Swiss Medical Weekly 2003, 133(9-10), 131-142.
  • Young A. Core psychiatry. British Journal of Psychiatry 2001, 179(4), 374-374.
  • McKeith IG. Alzheimer's disease and related disorders: Etiology, pathogenesis and therapeutics. Review. Aging & Mental Health 2000, 4(1), 91-91.